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SUMMARY
CONTROL OR CHOLESTEROL CATABOLISM IN 1UT LIVER
This study is concerned with the mechanisms which
control the activity of rat liver microsomal cholesterol
7R. -hydroxylase. This enzyme is thought to catalyse the
rate limiting step in the catabolism of cholesterol to
bile acids. Previous assays used to measure the enzyme
activity have involved the addition of a tracer amount of
radioactive cholesterol to rat liver microsomal suspensions
and measurement of the rate of formation of radioactive
product. This procedure assumes that the added tracer
equilibrates rapidly with all the endogenous cholesterol
and that the total substrate pool size is the same in
different microsomal preparations. An assay has been
developed which measures the total mass of cholest-5-ene-3^ ,
7o< -diol (7o^ -hydroxychol es tero 1) formed during incubations.
This method does not involve any of the assumptions inher¬
ent in the radioactive tracer assay. The procedure involves
purification of the 7o(. -hydroxycholesterol by thin layer
chromatography, followed by acetylation and finally compu¬
tation by gas liquid chromatography. Using this method it
was shown that radioactive tracer cholesterol added in
acetone solution equilibrates rapidly with virtually all
the endogenous microsomal cholesterol. This gas liquid
chromatographic assay was used to investigate the activity
of rat liver microsomal cholesterol 7oi. -hydroxylase under
various physiological conditions. The activity of the
enzyme in control rats was found to depend on the diet on
which the animals were maintained. The activity of the
enzyme was significantly greater when animals were fed the
commercial pellet diet than when they were fed a semi¬
synthetic soft diet. Cholesterol 7oi. -hydroxylase activity
was compared with the rate of hepatic cholesterol bio-
,-14.
synthesis measured using (1 C) acetate. Cholesterol
feeding, which inhibits cholesterol synthesis from acetate
in rat liver, was shown to stimulate cholesterol 7o< -
hydroxylase to a small but significant extent. .starvation,
which inhibits hepatic cholesterol synthesis, also inhibited
cholesterol 7«g. -hydroxylase. However, biliary drainage was
found to stimulate cholesterol 7oC. -hydroxylase activity in
the starved rat. Cholestyramine feeding, which inhibits
the absorption of both bile acids and cholesterol from the
gut, stimulated both hepatic cholesterologenesis from
acetate and cholesterol 7ot -hydroxylase, in agreement with
previous reports. Tomatine feeding, which inhibits the
intestinal absorption of cholesterol but not bile acids,
stimulated hepatic cholesterologenesis but not cholesterol
7e< -hydroxylase. These results suggest that hepatic
cholesterol biosynthesis and degradation are controlled
by independent mechanisms.
Eat liver microsomal cholesterol 7cg. -hydroxylase
requires NAHPH and molecular oxygen and involves an elec¬
tron transport system having cytochrome P450 as the
terminal oxidase. A large variety of drugs and foreign
compounds are oxidised in liver microsomes by a similar
mechanism. Experiments have been performed which show
that the 7<*. -hydroxylation of cholesterol and the oxidation
of drugs are controlled by different mechanisms in vivo.
Evidence has been presented which suggests that this may
be due to the presence of different rate limiting steps in
the enzyme systems. It is suggested that the rate limiting
step in the 7cX -hydroxylation of cholesterol might be the
formation of an enzyme-cholesterol complex.
The specificity of the cholesterol 7o^ -hydroxylase
enzyme has been investigated by comparing the liver micro¬
somal oxidation of cholesterol with that of several sterols
having a similar structure to cholesterol. The substrates
used were -hydroxyandrost-5-ene-17-one, 3(^ -hydroxypregn-
5-ene-20-one, androst-5-ene-3 ^ -ol and pregn-5-ene-3 -ol.
All of these sterols were metabolised to one or more
products when incubated with rat liver microsomes, NADPH
and oxygen. The former three sterols gave a Type I
difference spectrum with liver microsomes suggesting that
they might be oxidised by a mechanism involving cytochrome
P450. Pregn-5-ene-3 (| -o 1, however, gave no difference
spectrum and its oxidation was inhibited by ^-mercaptoethy-
lamine suggesting that a peroxidative mechanism might be
involved. Treatment of rats with cholestyramine, which
increased the activity of liver microsomal cholesterol
7c< -hydroxylase, had no effect on the rate of oxidation of
any of the four sterols studied. This suggests that
either these sterols are oxidised by different enzyme
systems from that involved in cholesterol 7o( -hydroxylation,
or that different rate limiting steps are involved in the
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The major quantitative pathways for cholesterol cata-
bolism in mammals are bile acid synthesis and the excretion
of faecal neutral sterols (Siperstein et al 1952). Elimina¬
tion of sterols via skin and urine and the synthesis of
steroid hormones are quantitatively of minor importance.
The liver is the only organ known to convert cholesterol
into bile acids, the end products being the ^24 compounds
cholic and chenodeoxycho1ic acids (review by Elliot and
Hyde 1971). The major enzymic pathway for cholic acid
formation in rat liver is thought to be that shown in Fig.2,
while chenodeoxycho1ic acid is formed by the same route,
but omitting the 1 2c< -hydroxylation (step D).
These primary bile acids are conjugated with either
taurine or glycine and in the form of the sodium salts they
are secreted via the bile duct into the duodenum. In the
gut, bile salts are functional in the emulsification of
dietary fat prior to its digestion by pancreatic lipase, in
the activation of this lipase and in the efficient absorption
of dietary lipids by the cells of the intestinal mucosa.
Bile salts are further metabolised by micro-organisms
present in the caecum and terminal ileum. Bile acids
extracted from faeces are entirely unconjugated and several
species of Clostridium and Enterococcus have been shown to
effect xhe hydrolysis of the peptide bond of the taurine
and glycine conjugates. Cholic and chenodeoxycholic acids
can be 7-dehydroxylated to deoxycholic and lithocholic
acids respectively by certain organisms, for example an
2
anaerobic Lactobacillus. Other transformations which occur
are the oxidation of hydroxyl groups to the ketones and
reduction of the ketones to give bothc^ and (»>-hydroxylated
epimers (review by Danielsson and Tchen 1968). The caecum
and the lower part of the ileum adsorb certain of these
secondary bile acids along with unchanged primary bile
acids. These return via the portal blood to the liver
where they are further metabolised and resecreted, consti¬
tuting an enterohepatic circulation of bile salts. In the
rat, approximately 90fo of bile salts are reabsorbed from
the intestine, but faecal losses are compensated by
continual synthesis from cholesterol in the liver, thus
keeping the total circulating pool relatively constant.
It has been calculated that in the rat this pool is
circulated ten to thirteen times per day (Shefer et a1
1969). The role of intestinal micro-organisms in
regulating bile acid metabolism has been investigated
usingrats raised under germ-free conditions (Grustaff'son
et a1 1957). It was found that the half-life of cholic
acid was three to five-fold greater in germ-free rats
than in conventional animals. Alterations in the rate of
bile acid metabolism produced by administering different
dietary regimens might be secondary to changes in the
composition of the intestinal flora. A dietary effect
was reported by Portman and Murphy (1958) who found that
the bile acid excretion rate in rats with a biliary fistula
was considerably lower when the animals were fed a purely





Figure 3 The enterohepatic circulation of cholesterol and
bile acids in man (from Bergstrom, 1959).
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Other compounds which undergo enterohepatic circulation
are the bile pigments, steroid metabolites (review by Taylor
1971), and to a lesser extent, cholesterol. Cholesterol is
secreted from the liver via the bile duct to the small
intestine where it mixes with dietary cholesterol. A
portion of this is reabsorbed via the lymphatic system and
returns to the liver via the systemic circulation incor¬
porated into chylomicrons. The neutral sterol fraction of
faeces is composed of cholesterol, other steroids of
endogenous origin such as 5 (/> -cholestan-3 (h -ol ( choles tano 1)
and microbial degradation products of cholesterol such as
5 ^-cholestan-3 Q> -ol ( coprostanol) . The enterohepati c
circulation of cholesterol and bile salts is shown
diagrammatically in Fig. 3.
If the circulation of bile salts is prevented, either
by inserting a cannula into the common bile duct and drain¬
ing the bile externally, or by feeding the anion exchange
resin cholestyramine which binds bile salts at the pH of
the small intestine, and prevents their reabsorption, the
liver responds by increasing the synthesis of bile acids
by as much as ten-fold (Eriksson 1957; Bergstrom and
Danielsson 1958). This suggests that there is a feedback
control by bile acids on their own synthesis. This hypo¬
thesis is supported by the results of Grundy et al (1966)
who reported that the administration of bile acids to man
suppressed endogenous bile acid production, and by the
results of Shefer et al (1969) who showed that the infusion
of sodium taurocholate into rats with a biliary fistula
prevented the increase in bile acid biosynthesis. Also
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ileal resection, which prevents the complete reabsorption
of bile acids, results in an increase in bile acid
biosynthesis (Playoust et al 1965).
Linstedt (1957) first suggested that the initial step
in the transformation of cholesterol to bile acids was the
7d, -hydroxylation reaction and circumstantial evidence
indicates that this enzyme may be rate-limiting in bile
acid formation. Biliary diversion in the rat results in
an increase in the activity of the cholesterol 7d -hydroxylase
enzyme (flanielsson e t al 1967; ohefer et al 1968; Boyd _et
al 1969). Thus it seems likely that the feedback control
of bile acid biosynthesis takes place at the level of this
enzyme. After complete drainage of bile salts from the
liver of a bile fistula rat, there is a lag period of
several hours before the increase in bile acid biosynthesis
occurs. This suggests that the feedback control is not
exerted by a direct effect of bile acids on the enzyme, but
rather that the induction of enzyme activity is due to the
synthesis of new enzyme protein. This is supported by the
results of Einarsson and Johansson (1968a) who demonstrated
that administration of inhibitors of protei n biosynthesis
prevented the induction of cholesterol 7d -hydroxylase
activity in the bile fistula rat.
These studies provide good evidence that prevention of
the resorption of bile acids from the gut accelerates bile
acid production, probably by increasing the activity of the
enzyme cholesterol 7oi -hydroxylase. However, the mechanism
whereby this feedback is exerted is obscure. It was shown
by Myant and Eder in 1961 that the increase in bile acid
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production following the insertion of a biliary fistula
into rats was preceded by an increase in hepatic cholesterol
biosynthesis. Danielsson e t al (1967) and Weis and Dietschy
(1969) have since demonstrated that the enzyme most affected
by this procedure is probably (^-hydroxy (^-methyl glutaryl
coenzyme A reductase (HMG CoA reductase) which is the major
rate-limiting enzyme in cholesterol biosynthesis in the
liver. Thus there appears to be a dual feedback mechanism
in the regulation of bile acid production. Biliary diversion
is accompanied by an increase in the activity of both
hepatic HMG CoA reductase and cholesterol 7cK -hydroxylase.
This has led to a great deal of discussion as to the
regulatory factors involved in hepatic cholesterol bio¬
synthesis and bile acid formation (Dietschy and Vilson
1970; Hamprecht et al 1971). The situation is complicated
by the fact that bile salts are required for the efficient
intestinal absorption of cholesterol, hence diversion of
bile salts from the small intestine prevents the feedback
of cholesterol to the liver. It is not yet clear as to
whether hepatic cholesterol biosynthesis and degradation
are both regulated by absorbed bile acids or absorbed
cholesterol or whether each system is regulated by an
independent mechanism. The interrelationships between
hepatic HMG CoA reductase and cholesterol 7oC -hydroxylase
are discussed in Section 4. Some experiments are
described which investigate the activity of rat liver
cholesterol 7ok -hydroxylase in relation to the rate of
hepatic cho1esterologenesis.
Figure 4 The 7o( -hydroxylation of cholesterol.
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The properties of the rat liver cholesterol 7o( -
hydroxylase enzyme have been extensively investigated in
this and in other laboratories (Mitton et al 1971; Shefer
et al 1968). It is located in the microsomal fraction of
rat liver and has an absolute requirement for NADPH,
oxygen and certain supernatant factors (Fig. 4). The
enzyme has been assayed by incubating a tracer amount of
radioactive cholesterol with liver microsomes and suitable
cofactors, followed by extraction, separation and quantita¬
tion of the radioactive sterols. It has been shown that
without the presence of 105,000 g liver supernatant, several
products are formed, namely 3 -hydroxycholest-5-ene-7-one
(7-ketocholestero 1) , cholest-5-ene-3 Q> , 7ot. -diol (7c* -
hydroxycholesterol) , cho 1est-5-ene-3,7q -diol (7<$ -
hydroxycholesterol) and cho 1 es tan-3 ,5ct ,6^> -triol.
However in the presence of cell supernatant and excess
NADPH there is selective formation of 7o( -hydroxycholesterol
(Mitton et al 1971). The supernatant can be replaced by
^ -mercaptoethylamine (Scholan and Boyd 1968) or by
glutathione and manganous ions (Grimwade 1971). The
formation of these other products, 'autoxidation products*
as they have been termed, occurs under the same conditions
as liver microsomal lipid peroxidation and it has been
suggested that they are formed by a similar mechanism
(Grimwade et al 1971). The possible mode of formation of
these products is shown in Fig. 5.
The use of the radioactive tracer assay in investi¬
gating the metabolism of cholesterol poses certain problems
due to the presence of appreciable amounts of endogenous
Figure 5 Suggested mechanism for the formation of choles¬
terol *autoxidation products* by rat liver
microsomes (from Mitton et al 1971).
(I) cholesterol, (II) 7o< -hydroxycholesterol,
(III) cholesterol 7oC-hydroperoxide, (IV) 7-
ketocholesterol, (V) 7 £-hydroxycholesterol,
(VI) cholesterol-5,6-oxide, (VII) cholestan-3^,
5o( ,6^ -triol.
cholesterol in liver sub-cellular fractions. It is possibl
that liver microsomal cholesterol is present in discrete
heterogeneous pools and that not all of this cholesterol
acts as substrate for the cholesterol 7(A -hydroxylase
enzyme. If the added tracer does not equilibrate
immediately with all the endogenous cholesterol, then the
use of the radioactive tracer assay could lead to erroneous
results, in particular when it is used to measure the
activity of the enzyme under different in vivo treatments
and dietary regimens. It is therefore desirable to
establish a means of measuring directly the amount of 7 oC -
hydroxycho1estero1 produced, thus obviating the need for
assumptions regarding substrate pool sizes or equilibration
of tracer. One of the aims of this work was to develop such
a method, hence providing a more reliable means of
investigating the physiological control of the enzyme.
Rat liver microsomal cholesterol 7-hydroxylase
requires NADPH and oxygen and thus falls into the class of
enzymes known as 'mixed function oxidases' (Mason 1957).
These reactions require a source of reducing equivalents
and molecular oxygen. One of the atoms in the oxygen
molecule is incorporated into the substrate and the other
is reduced to water. These enzymes involve an oxygen
activating component, and in a number of cases this com¬
ponent has been shown to be cytochrome P450, so termed
because of the spectrum of the reduced carbon monoxide
complex which has a maximum absorption at 450 nm. The
presence of this cytochrome was first demonstrated in
liver microsomes by Klingenberg and Garfinkel independently
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in 1958, but its presence has since been shown in a number
of other tissues, notably adrenal cortex. Enzymes which
involve this cytochrome as the oxygen activating species
are characterised by their inhibition by carbon monoxide,
the inhibition being maximally reversible by monochromatic
light at 450 nm. The first enzyme demonstrated to possess
this property was the steroid 21-hydroxylase from bovine
adrenal cortical microsomes (Estabrook et a 1 1963), but
since then many other enzymes have been implicated. These
include the 1 1 Q> -hydroxylation of deoxycorticosterone
(Omura et al 1965) and the side-chain cleavage of choles¬
terol to pregnenolone (Simpson and Boyd 1967) in bovine
adrenal cortex mitochondria.
The liver microsomal mixed function oxidase system
involving cytochrome P450 appears to catalyse the oxidation
of a large number of substrates of widely differing chemical
structures (review by Conney 1967). These include barbitu¬
rates such as phenobarbitone, carcinogens such as benzpyrene
and endogenous steroids such as testosterone, Liver
microsomal cytochrome P450 is thought to be reduced by an
electron transport system involving NADPH and a flavo-
protein (Orrenius and Ernster 1964). Cytochrome b^,
another cytochrome present in liver microsomes, has been
suggested to play a role in the reduction of cytochrome
P450 (Hildebrandt and Estabrook 1971).
The liver microsomal cytochrome P450-dependent
enzymes are induced following the administration to animals
of certain oxidisable substrates. The induction mechanism
appears to be non-specific in that the administration of
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one compound results in an enhancement of the ability to
oxidise in addition a large number of other substrates
(Conney 1967). The induction of enzyme activity is
paralleled by an increase in the content of cytochrome
P450 in the liver, suggesting that this component might
be rate-limiting in the overall hydroxylation mechanism.
There is evidence to suggest that there are two forms
of cytochrome P450, oneof whi^his induced on administration
of polycyclic hydrocarbons such as 3-methylcholanthrene,
and another form which is inducible by barbiturates, for
example phenobarbitone (Sladek and Mannering 1966). These
forms are thought to differ in the spin state of the haem
moiety. In the high spin state the five electrons in the
5d orbitals of the haem iron atom are unpaired, vhereas in
the low spin state there is only one unpaired electron. The
two forms can be distinguished by visible spectroscopy and
by electron paramagnetic resonance (Hildebrandt et al 1968;
Jefcoate and Gaylor 1969). 3-Methylcholanthrene induces
a form of the cytochrome having the properties of a high
spin haemoprotein, whereas phenobarbitone induces both the
low spin and the high spin forms. It is not known whether
these are two distinct haemoproteins or interconvertible
forms of the one haemoprotein. Cytochrome P450 is thought
to be the substrate binding site of the mixed function
oxidase system. tfhen oxidisable substrates are added to
oxidised suspensions of liver microsomes under aerobic
conditions, a characteristic difference spectrum is
observed (Remmer et al 1966) which is thought to be due to
spin-state transitions of the haem moiety of cytochrome P450
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(Hildebrandt et al 1968). Compounds producing this effect
have been classified as Type I or Type II according to the
characteristics of the difference spectrum. Type I com¬
pounds produce a difference spectrum having a maximum
absorption at approximately 392 nm and a minimum at
approximately 410 nm whereas the difference spectrum
produced by Type II compounds has a minimum at 390 nm
and a maximum at approximately 420 nm.
It has been shown in this laboratory that cytochrome
P450 participates in the 7 ot -hydroxylat i on of cholesterol
by rat liver microsomes (Boyd et al 1971). In this respect
cholesterol 7o(. -hydroxylation is similar to the oxidation of
drugs and steroids by liver microsomes. However cholesty¬
ramine feeding, which enhances cholesterol 7oC -hydroxylase
activity, had no effect on liver microsomal cytochrome P450
levels (Boyd et al 1969) suggesting that this component is
not rate-limiting in the hydroxylation of cholesterol by
liver microsomes. In Section 5 some experiments are des¬
cribed which investigate the relationship of the cholesterol
7-hydroxylase enzyme system to the other mixed function
oxidases of rat liver microsomes, with particular reference
to the nature of the rate-limiting step.
A number of endogenous steroid substrates are hydroxy-
lated by liver microsomes and it is of interest to establish
whether these are metabolised by the same enzyme system as
cholesterol. The specificity of liver microsomal cholesterol
7ot-hydroxylase has been studied by investigating the
metabolism of a variety of steroid substrates and comparing
their oxidation with that of cholesterol.
In summary, the aims of this research have been to
investigate the mechanisms whereby the rat liver microsoma
cholesterol 7o< -hydroxylase is controlled in vivo. The
regulation of this enzyme has been compared with that of
hepatic cholesterol biosynthesis and with the cytochrome





A. Animals and Their Diets
The animals used in these experiments were rats of the
Vistar strain weighing 150-250 g and were bred in the animal
unit of this department. Unless otherwise stated, male
rats were used.
Control diets used were a pellet diet, 'Oxoid* no.86
rat cake (75)5 whole meal flour, 20jS fish and bone meal and
5/' dried yeast) and a soft diet (70)o whole meal flour, 25/°
skimmed milk powder and 5)5 dried yeast).
The various dietary regimens used in some experiments
involved the incorporation of the additive into the soft
diet. Cholestyramine (•Cuemid', Merck, Sharp and Dohme)
was administered at a dose of 4)5 by weight in the diet for
at least five days. Tomatine (Koch-Light) was sieved before
mixing with the diet (1)5 by weight) and was administered for
six to eight days. In cholesterol feeding experiments
cholesterol (1)5 by weight) was dissolved in olive oil (10)c
by weight) and mixed with the diet. Controls received 10)5
olive oil in soft diet. Starved animals were kept without
food for 48 hours prior to death but were given water to
drink ad libitum.
B. Bile Duct Cannulations
A polyethylene cannula was inserted andtied into the
common bile duct and held in place outside the animal by
surgical tape. The animals were held under ether anaesthesia
throughout this procedure. They were kept in special
restriction cages and given an electrolyte solution of NaCl
(0 ' 7$) , NaHC03 (0«25$), KC1 (0*037$) to drink. Controls
were subjected to the same surgical stress but no cannula
was placed in the bile duct and they were given water to
drink.
C. Phenobarbitone Treatment
Sodium phenobarbitone was administered to rats in
their drinking water at a concentration of 1 mg/ml. This
treatment was continued for six to eight days.
D. 3-Methylcholanthrene Treatment
3-Methylcholanthrane was suspended in corn oil (Mazola)
and injected intraperitoneally at a dose of 20 mg/kg body
weight. Control animals received the same volume of corn
oil (0'5 ml). The animals were injected in this manner once
per day for three days and were killed on the fourth day.
E. Cycloheximide Treatment
Cycloheximide was dissolved in 0*9$ saline and the
animals received a single intraperitoneal injection at a
dose of 5 mg/kg body weight. Controls received the same
volume of saline (0'2 ml).
F. Preparation of Liver Microsomes
The animals were anaesthetised with ether and the
livers were immediately excised and weighed. In certain
experiments in which it was necessary to remove as much
haemoglobin as possible the liver was first perfused in
situ with 0'154 M KC1 through the portal vein. All subse¬
quent procedures were performed at 0-4°C. The liver was
























Figure fa Procedure for the extraction of steroids from rat
liver microsomal incubations.
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v/v) by three passes of a loosely-fitting Teflon/glass homo-
geniser. The crude homogenate was centrifuged at 18,000 g
for 15 minutes to remove nuclei, unbroken cells, cell debris
and the mitochondrial fraction. The 18,000 g supernatant
vas then centrifuged at 100,000 g for 1 hour to sediment
the endoplasmic reticulum as the microsomal fraction. The
microsomal pellet vas suspended in 0'1 M sodium phosphate
buffer pH 7'4, so that 1 ml of the final suspension vas
equivalent to 1 g vet veight of liver.
G. Radioactive Tracer Assay for Cholesterol 7 -Hydroxylase
Each incubation contained a microsomal suspension
derived from 1 g of liver buffered vith a total of 2 ml of
0'1 M phosphate buffer pH 7'4. NADPH vas added in the form
of a generator consisting of NADP (5 pmoles), glucose 6-
phosphate (50 pinoles) and glucose 6-phosphate dehydrogenase
(1 unit) in 1 ml of vater. (4-^C) cholesterol, purified
by thin layer chromatography prior to use, vas added to the
incubation medium in 0*05 ml of acetone (0*1 pC, specific
activity 60 mC/mM). The incubation medium also contained
10 mM (b-mercaptoethylaraine. Water vas added to give a
total volume of 7'0 ml.
Incubations vere conducted in air for 1 hour in a
shaking vater bath (100 oscillations/minute) at 37°G. The
optimal conditions for enzyme activity have previously been
established in this laboratory (Mitton et al 1971). The
reaction vas stopped by the addition of 10 ml of methanol.
Lipid vas extracted from the tissue according to the pro¬
cedure shovn in Fig. 6. The extract vas concentrated and
applied to a thin layer chromatography (TLC) plate of
Figure 7 Radioactive scans of thin layer plates of the
lipid extracts obtained after incubation of
1 4
(4- C) cholesterol vith rat liver microsomes
in the absence (A) and the presence (B) of
10 mM ^-mercaptoethylamine. The products are
identified in Fig. 5.
1 5
silica gel H (Merck) which was developed in a solvent
system of benzene:ethyl acetate: ;7:13 - The radioactive
compounds were located using a Panax thin layer scanner
and identified by their R_ values. The products obtained
r
from cholesterol have been characterised in this laboratory
(Mitton et al, 1971). The products were quantified by
removing the silica gel into liquid scintillation vials and
measuring the radioactivity in a Packard Tri-Carb liquid
scintillation spectrometer. The silica gel does not cause
significant quenching. The activity of the cholesterol
7 -hydroxylase enzyme was then expressed as percentage
conversion of added substrate to 7 ot -hydroxycholesterol.
Radioactive thin layer scans of the pattern of products
obtained from incubations with and without the inclusion of
*
10 mM(^-mercaptoethylamine are shown in Fig. 7. This thiol
is effective in preventing the formation of "autoxidation
products" of cholesterol by liver microsomes (Section 1).
H. The Determination of 7 cA -Hydroxycholesterol
The development of this procedure for determining 7o( -
hydroxycholesterol is discussed in detail in Section 3. The
method used is outlined in Fig. 8.
Incubations of liver microsomes were conducted as
1 4
already described but without the addition of (4- C)
cholesterol. After stopping the reactions with methanol,
3
( H) 7«( -hydroxycholesterol (0*04 ;iC) was added to each
flask. Lipids were extracted and subjected to TLC as
before, but standard 7cA -hydroxycholesterol was run at the
edge of each plate. This was located by spraying with











eluted from plate * by T.L.C. chloroform and ethyl acetate
1 (benzene:ethyl acetate)
1 ( 7 : 13 )
Acetvlation - Gas liauid chromatodraohv using
Pyridine/acetic anhydride cholesterol as internal standard






obtained almost immediately at room temperature. The area
of the plate corresponding to 7 <*> -hydroxycholesterol was
removed (without removing the standard) into a centrifuge
tube and the silica gel was extracted twice with dichloro-
methane. The extracts were combined and concentrated and
the 7<A -hydroxycholesterol was acetylated essentially
according to the method of Norymberski and Riondel (1967).
Each sample was applied in ether on to a small strip of
filter paper (watmans No. 1) 3 cm by 0'8 cm which was
then suspended from a glass hook in a sealed vessel above
a mixture of dry pyridine and acetic anhydride (2:1 v/v).
This vessel could incorporate eight filter papers at one
time. The samples were left to acetylate at room tempera¬
ture for at least 16 hours. This procedure results in
complete conversion to the diacetate. The filter papers
were dried in air and eluted with 10 mis of dichloromethane.
1 ml was removed into a scintillation vial, evaporated and
counted in the Packard liquid scintillation spectrometer.
This gave an estimation of the efficiency of the recovery
of the procedure. The remainder was concentrated and a known
quantity of cholesterol was added as an internal standard for
gas liquid chromatography (GLC). A sample of this mixture
was injected on to the GLC column in acetone. (The condi¬
tions for chromatography are described below.) The cholest-
5-ene-3 , 7 <A -dio 1 diacetate in the sample was quantified1,
by comparing the ratio of the heights of the peaks obtained
for the diacetate and cholesterol with a standard curve of
actual ratio versus peak height ratio. This value was
corrected for recovery losses and hence the mass of 7o< -
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hydroxycholesterol formed during the incubation was calculated,
The enzyme activity was expressed as moles of 7p< -hydroxy¬
cholesterol formed per minute per mg of protein. Microsomal
protein was measured by the biuret method.
I. Conditions for Gas Liquid Chromatography
All gas chromatographic work was carried out on a Pye
104 gas chromatogram equipped with a flame ionisation
detector. Columns were lv'75 metres long of 4 mm i.d. glass
tubing silanised with dichlorodimethylsilane. The liquid
phase used was 1 fo SE 30 on 100-120 mesh Gas-Chrome Q
(Applied Science Laboratories Inc.). The column oven
temperature was 235°C, the injection port temperature was
300°C and the detector oven temperature was 240°C. Nitrogen
was used as carrier gas at a flow rate of 30 ml per minute.
J. The Determination of Cholesterol
Microsomal cholesterol was measured by gas liquid chro-
14 >.
matography. (4- C) cholesterol (60 mC/mMole^was added to the
microsomal sample as an internal standard for recovery.
Lipid was extracted with chloroform-methanol (1:1 v/v)
and chromatographed by TLC in a solvent system consisting
of di-isopropy1ether: petroleum spirit: :70:30. The area
corresponding to cholesterol was located using the Panax
thin layer scanner and removed into a centrifuge tube.
Cholesterol was extracted from the silicagel using chloroform-
methanol and a sample was removed for liquid scintillation
counting. A sample of the remainder was applied to a GLC
column using pregnenolone acetate as an internal standard.
The conditions used are described above. The mass of
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cholesterol was calculated by measuring the ratio of the
peak heights and comparing with a standard curve as
already described for 7oC -hydroxycho 1 estero 1. This value
was corrected for losses on the basis of the calculated
1 4
recovery of the C standard.
Total liver cholesterol was measured by the Liebermann-
Burchardt colour reaction.
K. Assay for Aminopyrine Demethylase
Aminopyrine is N-demethylated by liver microsomes in
the presence of NADPH and molecular oxygen with the produc¬
tion of formaldehyde (Ernster and Orrenius, 1966).
The incubation medium used was the same as that for the
cholesterol 7 c*. -hydroxylase assay, but omitting radioactive
cholesterol and <£ -mercaptoethylamine and incorporating 10 mM
aminopyrine. The reaction was conducted in air at 37°C for
40 minutes, and stopped with 0'5 ml of 60<fo perchloric acid.
The formaldehyde produced during the incubation was assayed
according to method of Nash (1953). The reaction mixture
was centrifuged to remove denatured protein and the super¬
natant was incubated with an equal volume of the formaldehyde
reagent (2 M ammonium acetate, 0'05 M acetic acid, 0'02 M
acetyl acetone) at 37°C for 40 minutes. The optical density
of the resulting yellow colour was read in a Unicam 3P 600
spectrophotometer at 412 nm and the concentration of formal-
-3
dehyde calculated using an extinction coefficient of 8 x 10
The enzyme activity was expressed as moles of formaldehyde
produced per minute per mg of microsomal protein.
L. Assay for Cholesterol Biosynthesis
Animals were anaesthetised vith ether and the livers
were rapidly removed, minced and homogenised in three
volumes of Bucher's medium (Bucher et al, 1 959; T..ble 1).
The homogenate was centrifuged at 18,0UU g for 15 minutes
to remove nuclei, cell debris, unbroken cells and the
mitochondrial fraction and the resulting supernatant was
used in the incubations. The incubation medium is shown
in Table 2 and the reaction was carried out at 37°C for 3|
hours. The reaction was stopped with 10 mis of 10;6 KOH in
3
methanol (w/v), a sample of (7«< - II) cholesterol was added
as a recovery indicator and the mixture was refluxed under
nitrogen. Lipid was extracted vith chloroform and boiling
ethyl acetate, the extracts were combined, washed with
sodium bicarbonate solution, concentrated and subjected to
TLC in a solvent system of di-isopropylether:petroleum
spiritj :70!30. The area of the plate corresponding to
cholesterol vas removed into a scintillation vial and
1 4
counted as described previously. The incorporation of C
from (1-^C) acetate into cholesterol was corrected for
3
losses as measured by the recovery of (7tA- H) cholesterol.
The rate of cholesterol biosynthesis from acetate was
1 4
expressed as counts per minute of C incorporated per
incubation.
M. Determination of Cytochrome P450
Cytochrome P450 estimations were carried out essenti¬
ally according to the method of Omura and Sato (1964) in
an Aminco-Chance spectrophotometer with the instrument in







0.1 M potassium phosphate buffer, pH 7.4
Table 2
Incubation medium for cholesterol biosynthesis in vitro
2 ml Bucher's medium
1 jimole NADP
5 jimoles Glucose-6-phosphate




5 mM sodium acetate
1 4
10 jiC sodium (1- C) acetate (29 mC/mM)
2 ml liver 18000 g supernatant
21
optical density at 450 nm relative to 490 nm. Liver micro¬
somes vere suspended in 0*1 M phosphate buffer pH 7'4 at
a concentration of 1-3 tag protein per ml, a few grains of
sodium dithionite vere added to reduce the cytochromes and
a zero reading was made in the spectrophotometer. Carbon
monoxide gas was then bubbled through the cuvette for 20
seconds and a new reading was made. The amount of
cytochrome P450 was calculated using an extinction coeffici-
—3 _l
©nt of 91 x 10 M (Omura and .Sato, 1964) and was expressed
as nmoles per rag of microsomal protein.
N. Assay of NADPH Cytochrome c Reductase Activity
The rate of this reaction was measured using the Aminco-
Chance spectrophotometer in the dual wavelength mode. The
increase in optical density at 551 nm relative to 540 nm was
measured. The cuvette contained 2'5 ml 0'1 M phosphate
buffer pH 7'4. 0»2 ml NADPH generator (1 }i mole NADP, 10 p
mole glucose 6-phosphate, 0'2 I.U. glucose 6-phosphate
dehydrogenase) and 0'05 ml of microsomal suspension and the rpa^tion
was allowed to proceed for 2-3 minutes. The rate of the reaction
was calculated using the initial slope of the line obtained
and an extinction coefficient for reduced cytochrome c at
-3
551 nm of 19 x 10 M. The rate vas expressed as nmoles of
cytochrome c reduced per minute per mg protein.
0. Measurement of Difference Spectra
Microsomal difference spectra were obtained using the
Aminco-Ohance spectrophotometer set in the split-beam mode.
Microsomal suspensions containing 2-3 mg protein per ml of
phosphate buffer pH 7'4 were divided between two cuvettes.
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The spectrum was scanned from 370 to 450 nm with and without
the addition of a solution of the compound under study to
the sample cuvette, the same volume of solvent being added
to the reference cuvette. Increasing the concentration of
the compound results in an increase in the difference in
optical density between the minimum and maximum wavelengths
of the difference spectrum until saturation is achieved.
The binding constant (Ks) for the compound is the concen¬
tration at which this difference in optical density is
half-maximal.
P . Preparation of Androst-5-ene-3 C> -ol and Pregn-5-ene-3 0> -o 1
These compounds, the ketone reduction products of dehy-
droepiandrosterone and pregnenolone respectively, were pre¬
pared using the Huang-Minion modification of the Volf-Kishner
method for the reduction of ketones (Huang-Minion 1949).
1 g of steroid, 2 g potassium hydroxide, 0'5 mis of
hydrazine hydrate and 50 mis triethylene glycol were refluxed
together for approximately 0.5 hours to form the hydrazone.
Vater and excess hydrazine were removed by heating without
the reflux condenser until the temperature rose to 195-200°C
and refluxing was continued for a further 2 hours to decom¬
pose the hydrazone. The cooled solution was diluted with
10 mis of water and extracted four times with ether. The
ether extract was washed once with water and evaporated
to dryness.
Andros t-5-ene-3 (^>-o 1 was recrystallised from ethyl
acetate to give white needles.
m.p. 133-135°C (literature value 132-133°C)
TLC in ethyl acetate: benzene: :5:1: One spot R 0'82
r
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Pregn-5-ene-3^ -ol vas recrystallised from methanol,
m.p. 134-136°C (literature value 133-134°C)
TLC in ethyl acetate:benzene: :5:1s One spot R 0*84.
r
Mass spectra were obtained for these compounds using
a Hitachi Perkin-Elmer RMU 6E mass spectrometer. Molecular
weights for androst-5-ene-3 (b -ol and pregn-5-ene-3(^> -ol
were confirmed as 274 and 302 respectively.
Q• The Preparation of Tritiated jadrost-5-ene-3Q> -olt
Pregn-5-ene-3 -ol and CholBst-5-ene-3ft,7<A-diol
These steroids were tritiated according to the method
of Wilzbach (1957). A sample of the compound (5 mg) vas
spread in a thin film around a flask which was exposed to
tritium vapour at low pressure for four days. The steroid
was repeatedly washed with methanol to remove free tritium
and then purified by TLC (ethyl acetate:benzene: :5s1) to
remove polar degradation products.
Steroid Specific Activity
7
androst-5-ene-3 -ol 2'0 x 10 d.p.m. per mg
g
pregn-5-ene-3^-o1 1*0 x 10 d.p.m. per mg
7
cholest-5-ene-3(*>, 7c^-diol 2'0 x 10 d.p.m. per mg
R. Assay for the Microsomal Oxidation of Dehydroepiandros-
terone. Pregnenolone, Androst-5-ene-3 -ol and Pregn-
5-ene-3 ^ -ol
The assay medium was the same as that used for choles¬
terol oxidation, but omitting -mercaptoethylamine and
/ 14s
(4- C) cholesterol, and incorporating the radioactive
steroid whose oxidation was being studied. The steroid was
diluted to the required specific activity and 0'1 jiC was
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added in acetone to the incubation medium. (4-^C) dehydro-
epiandrosterone and (4-^C) pregnenolone (60 mC/mM) were
3
obtained from the Radiochemical Centre, Amersham. ( H)
3
andros t-5-ene-3 (*> -o 1 and ( H) pregn-5-ene-3 (i -o 1 were
prepared as already described. The oxidation of these
compounds by liver microsomes is discussed in Section 6.
The reactions were stopped with methanol and lipid was
extracted exactly as described for cholesterol 7dk -hydroxy¬
lase (Fig.6). The radioactive steroids were separated by
TLC using a solvent system of ethyl acetatejbenzene: :5 s1
and counted by liquid scintillation spectrometry. The per¬
centage conversion of substrate to product was calculated
and the enzyme activity expressed as moles of product formed
per minute per mg of microsomal protein.
S. Reagents and Materials
All reagents were of Analar grade and were supplied by
B.D.H. or Bigma unless otherwise stated. Glucose 6-phosphate
and NADP were supplied by Boehringer. Acetone was redis¬
tilled after refluxing with potassium permanganate. Methanol
and ethanol were refluxed with potassium hydroxide before
redistilling. Dichloromethane was also redistilled before
use. The toluene for liquid scintillation counting was
washed with concentrated sulphuric acid, then with water and
"1 4
finally dried over sodium sulphate. (4- C) cholesterol
obtained from the Radiochemical Centre, Amersham, was
purified by TLC on Keiselgel H (Merck) using a solvent




AN ABSOLUTE ASSAY FOR CHOLESTEROL 7ot -HYDROXYLASE
A. Introduction
Colorimetric methods for determining 7oC -hydroxycholesterol
are not sufficiently sensitive to measure the amounts of this
steroid vhich can be formed during an incubation of liver
microsomes. For example, the Lifschutz reaction (Bergstrom
and Wintersteiner, 1942) is suitable for measuring quantities
of the order of 100 ;ug. Thus the method vhich has been
used in this and in other laboratories has involved the
addition of exogenous radioactive cholesterol to liver
subfractions and measuring the percentage of radioactivity
incorporated into the product, 7 c<-hydroxycholesterol
(Mitton et al, 1971; Danielsson et al, 1967; Shefer et al
1968). Using this method to compare the enzyme activity in
the livers of different animals involves tvo assumptions:
(1) that the total pool of cholesterol in the liver
subfractions is the same,
(2) that the added exogenous tracer cholesterol
equilibrates vith all the endogenous cholesterol.
Liver microsomes contain considerable amounts of endo¬
genous cholesterol, on average approximately 500 nmoles per
g of liver microsomes. This cholesterol pool is not neces¬
sarily homogeneous* Cholesterol is continually being synthe-
sised and degraded in the liver and is also derived from
intestinal absorption. Cholesterol has also a structural
function in the membranes of the endoplasmic reticulum.
Thus under different physiological conditions vhen the
relative sizes of these pools may be altered, the distribution
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of exogenous radioactive cholesterol between the different
pools may also change. It therefore seemed desirable to
establish a method for measuring directly the total mass of
7 Ot -hydro xycho le s t e ro 1 formed from endogenous cold choles¬
terol in liver microsomal incubations. Measuring the
disappearance of the substrate, cholesterol, would not be a
suitable means of assaying the enzyme due to the small
proportion of the endogenous cholesterol which reacts during
the period for which the time course of the reaction is
linear.
A method was already in use in this laboratory for
measuring pregnenolone formed from cholesterol in the side
chain cleavage reaction of adrenal mitochondria (Simpson
al 1971). This involves purification of the pregnenolone
followed by reaction with a 3 (b -hydro xys t ero id dehydrogenase
from Pseudomonas testosteroni to form progesterone. The
NAI)H formed during the reaction is then assayed by its
fluorescence emission at 457 nm when irradiated with light
at 340 nm. Although this bacterial steroid dehydrogenase
is a fairly non-specific enzyme which reacts with a wide
spectrum of 3^-hydroxysteroids, it was shown not to react
with 7 c*. -hydroxycholestero 1.
The next method of choice was gas liquid chromatography,
which was already in use in this laboratory for measuring
cholesterol. However 7(*■ -hydroxycholestero 1 was found to
decompose on injection on to the GLG column. Under the
conditions necessary to volatilise it, this compound gave
at least three distinct peaks. This is in agreement with
the results of Van Lier and Smith (1967), who suggest that
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the major decomposition product might be similar to A' -
cho 1 estadiene . These workers have shown that the 3^3 , 7o< -
diacetate of 7 o(, -hydroxycholesterol does not decompose and
so it was decided to attempt derivative formation combined
with GLC to assay 7oC -hydroxycholesterol. The most efficient
method of forming the diacetate was found to be that des¬
cribed in Section 2. Here the derivative is formed by
subjecting the diol adsorbed on filter paper to the vapours
of the reactants pyridine and acetic anhydride. 16 hours at
room temperature was found to give complete conversion.
This method has been described by Norymberski and Riondel
(1967) and is particularly convenient for GLC since there
is no problem in removing the pyridine which is relatively
involatile and gives a broad peak on GLC. In some experi¬
ments the diacetate was first purified by TLC in benzene:
ethyl acetate: :9:1.
® • The Behaviour of Cho lest-5-ene-3 & , 7 ot, -diol diacetate
on Gas Liquid Chromatography
Using the GLC conditions described in Section 2,
cholest-5-ene-3 ^ , 7<?(. -diol diacetate gave a single symmetri¬
cal peak with a retention time relative to cholesterol of
0'64. This is in contradistinction to the results of Van
Lier and Smith (1967) who showed a retention time relative
to cholsterol of 1*69 on SE 30 columns. It seemed possible
that under our conditions the diacetate decomposes to give
a product having a shorter retention time. There was no
trace of any peak at longer retentions, suggesting that
total decomposition occurs. To determine if the peak
obtained for the diacetate in these experiments was a
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decomposition product, GLC coupled to mass spectrometry vas
used. The peak obtained was identified as a cholestatriene.
The identification of this compound is described in
Appendix 1.
Assuming complete decomposition of the diacetate to a
single product, it should be valid to use measurement of
this decomposition product as an assay for 7oC-hydroxy-
cholesterol. This assumption is based on the fact that a
single symmetrical peak vas obtained and that the calibration
curves such as that shown in Pig. 10 were consistent. The
check of the assay procedure is shown in Fig. 11 (Part D of
this section).
C. The Specificity of the Method
The separation of the lipid extract of liver micro¬
somes by TLC should be sufficient to purify 7-hydroxy-
cholesterol from other products of the liver microsomal
metabolism of cholesterol. Also, the conditions of the
incubation are such that there should be selective formation
of 7o( -hydroxycholesterol. The exclusion of NAD prevents
the formation of 7 oC -hydroxycho 1 est-4-ene-3-one , the next
intermediate in bile acid biosynthesis, and the inclusion
of ^ -mercaptoethylamine inhibits the formation of
'autoxidation products' of cholesterol (section 1). However,
the behaviour of possible 'autoxidation products* of micro¬
somal cholesterol metabolism on the GLC column were
examined in order to find out to what extent they would
interfere with the estimation of 7 oC -hydroxy cho le s te ro 1.
These steroids (Mitton et al, 1971) were subjected to the
same acetylation procedure as described for 7ct -hydroxycholesterol,
1%S.E. 30
COLUMN TEMP 235°C
CARRIER GAS FLOW 30ml/minute







Figure 9 Gas liquid chromatographic elution pattern of
cholest-5-ene-3 ,7^ -diol diacetate and
cholesterol injected in acetone solution.
Figure 10 Calibration curve for c ho 1 es t-5-ene-3 , 7cJ, -diol
diacetate and cholesterol on GLC.
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The retention times relative to cholesterol using the GLC
conditions described in Section 2 are shown below.
Sterol Acetate Relative Retention
cholest-5-ene-3 ^,7 ^-diol 0'64
cholest-5-ene-3 (*, ,7 -diol 0*64
3 ^-hydroxycholest-5-ene-7-one 1'15
Cholestan-3 , 5 oC ,6^ -triol 2'28
Thus the method does not distinguish between the epi-
meric diols, 7 ot and 7Q> -hydroxycholesterol, however the
other 'autoxidation products* of cholesterol are well
resolved.
F• Calibration of the Assay for 7 <A -Hydroxycholesterol
The chole*t-5-ene-3 <^> , 7<A -diol diacetate in each sample
was estimated by GLC using cholesterol as an internal
standard, measuring the ratio of the heights of the peaks
obtained and computing using a calibration curve. Fig. 9
shows the trace which is obtained on injection of a mixture
of these two compounds in acetone. A typical calibration
curve is shown in Fig. 10. A curve such as this was
obtained for each experiment and the mass of 7 (A -hydroxy¬
cholesterol formed during an incubation was calculated as
described in Section 2. The method was checked by adding
known quantities of 7oC -hydroxycholesterol to liver micro¬
somes and comparing with observed values. Fig. 11 shows
the correlation between the calculated mass of 7oi -
hydroxycholesterol and the actual mass.
Figure 11 Check of the GLC assay for 7c* -hydroxycholesterol.
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E. The Sensitivity of the Method
The amount of 7o(. -hydroxycholestero 1 lost during the
procedure of extraction, thin layer chromatography and
acetylation can be calculated on the basis of the recovery
of the standard ( II) 7t< -hydroxycho 1 estero 1 added at the
end of the incubation. The recovery obtained at each stage
of the procedure is shown below for a typical experiment






Added Standard 9850 100
Af te r extraction from microsomes 9280 94
After TLC 7570 77
After extraction from silica gel 5840 59
After acetylation 4520 46
The final recovery was found to vary between 35% and
55%. A full scale deflection of the recorder attached to the
gas liquid chromatogram corresponded to 1'6 pg of cholest-
5-ene-3 , 7 -diol diacetate. Considering the losses
during extraction, acetylation and injection on to the G-LC
column, the method was estimated to be sensitive to 1 fig
of 7d -hydroxycholesterol. The precision of the method was
determined by making several estimations on the same amount
of 7ck -hydroxycholesterol. Six samples of 5*0 pg of 7o(. -
hydroxycholesterol gave an observed value of (4'9 - 0*3) pig.
The radioactive tracer assay is sensitive to approxi¬
mately 0'5% conversion of added (4-^C) cholesterol.
Assuming complete equilibration of tracer with endogenous
substrate, this corresponds to approximately 1 fig of
Figure 12 Tin* course of 7c< -hydroxycholesterol formation
as measured by the radioactive tracer assay and
the GLC assay.
Figure 13 The effect of microsomal protein concentration
on the rate of formation of 7c< -hydroxycholesterol.
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cholesterol, hence the GLC assay is no more sensitive than
the radioactive assay. The precision of the radioactive
assay was assessed by conducting identical incubations. A
typical experiment in which six samples of microsomes were
incubated for 1 hour gave a value of (7'18 - 0*11 )#
conversion.
The GLC assay is advantageous in that it makes no
assumptions regarding cholesterol pool sizes or tracer
equilibration.
F. Comparison of the GLC Assay for Cholesterol 7 cA -
Hydroxylase with the Radioactive Tracer Assay
The radioactive tracer assay for cholesterol 7 cA -
hydroxylase assumes that exogenous (4-^C) cholesterol
equilibrates with all the endogenous microsomal cholester¬
ol. If this is so, then the amount of 7tA -hydroxycholesterol
formed as calculated by this method should not differ sig¬
nificantly from the value obtained using the GLC assay.
Fig. 12 shows a time course for 7 cC -hydroxycholesterol
formation calculated using the two assays. Total micro¬
somal cholesterol was estimated by GLC. The initial rate
of formation is approximately the same in each case,
suggesting that the assumption of total equilibration of
tracer is valid.
G. The Effect of Microsomal Protein Concentration on
7 c*. -Hydroxycholesterol Formation
The amount of 7 cA-hydroxycho les fcerol formed after
incubating different concentrations of microsomes was
measured using the GLC assay. Fig. 13 shows that the
reaction is first order with respect to protein concentration.
Figure 14 The effect of 7c< -hydroxycholesterol on cholesterol
7o( -hydroxylase in vitro.
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H. The Effect of 7pC -Hydroxycholesterol on Cholesterol
7 c* -Hydroxylase
The effect of the product, 7pC-hydroxycholesterol, on
cholesterol 7 o< -hydroxylase activity is shovn in Fig. 14.
The concentration in the initial incubation medium required
for 50$ inhibition is approximately 25 pM. The amount of
7 c*-hydroxycholesterol formed after one hour's incubation
in the experiment described in Part F of this section was
12 ^ig. The largest value obtained in any experiment vas
21 jig, which corresponds to a concentration of 7'5 ;uM.
Thus accumulation of product is unlikely to have much
effect on the reaction rate. The conditions used for
assaying the enzyme are such that 7 (X -hydroxycholestero 1
accumulates in the incubation medium. In vivo, howeyer,
the presence of NAD together with the active 3(i-ol
dehydrogenase present in liver microsomes (Hutton and
Boyd, 1966; Berseus et al, 1969) results in efficient
conversion to 7©C -hydroxycholest-4-ene-3-one and 7<* -
hydroxycholesterol does not accumulate to any great extent.
Thus product inhibition is unlikely to play an important
physiological role in controlling enzyme activity.
SUMMARY TO SECTION 3
1) An assay procedure has been developed to determine
quantitatively the mass of 7<* -hydroxycholesterol produced
in liver microsomal incubation.
2) The values obtained using this method agree closely
with those obtained using the radioactive tracer assay,
suggesting that exogenous tracer cholesterol added in
acetone solution equilibrates rapidly with all the
endogenous microsomal cholesterol.
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3) The rate of formation of 7(* -hydroxycholesterol is first
order with respect to microsomal protein concentration.
4) Cholesterol 7oC. -hydroxylase is inhibited by the product
of the reaction, 7 oC -hydroxycholestero 1, but at concentra¬




THE CONTROL OF CHOLESTEROL 7 c<-HYDROXYLASE ACTIVITY
IN VIVO
A. Introduction
Cholesterol 7<X -hydroxylation is "th© initial step in the
catabolism of cholesterol to bile salts and is also thought
to be rate-limiting (Danielsson et al, 1967; Shefer et al,
1968, 1970; Boyd et al, 1969). Hence agents which alter
the activity of this enzyme in vivo will affect the rate at
which cholesterol is degraded. Since bile acid formation
is quantitatively the most important pathway of cholesterol
catabolism, agents which activate this pathway have been
used in an attempt to lower serum cholesterol levels. For
example, cholestyramine, an anion exchange resin which
binds bile salts in the small intestine and so inhibits their
reabsorption, stimulates bile acid production and has been
used effectively to lower serum cholesterol levels in man
(Bergen e t ai, 1 959). However, in the rat cholestyramine
feeding did not significantly lower serum cholesterol
levels (Huff et al, 1963). In this animal hepatic choles¬
terol biosynthesis is markedly increased following biliary
drainage (Myant and Eder, 1961) and it has since been shown
that the enzyme whose activity is most affected by this
procedure is HMO CoA reductase (Danielsson et al, 1967;
Weis and Dietschy, 1969). Thus in the rat the steady state
levels of cholesterol in the whole animal are not signifi¬
cantly altered by biliary diversion. The control of
cholesterol metabolism in man and other species is discussed
in Section 7.
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Myant and Hder (1961) showed that in the biliary
fistula rat the increase in cholesterol biosynthesis
preceded by several hours the increase in bile acid bio¬
synthesis. These workers suggested that bile acid
formation increased as a consequence of the enhancement of
cholesterol biosynthesis. It is possible that the precursor
of bile acids is endogenously synthesised cholesterol and
that the rate of supply of this precursor controls the rate
at which bile acids are formed. Cholesterol 7o<. -hydroxylase
activity would then depend on the availability of the
substrate cholesterol. Other evidence which links cholesterol
7oC -hydroxylase and cholesterol biosynthesis is the fact that
cholesterol 7-hydroxylase undergoes a diurnal variation
in activity (Renson et a 1 1 969), a property which is shared
by the major rate limiting enzyme in cholesterol biosynthesis,
HMG CoA reductase (Hamprech^ et al 1 969). Recently Alam
and Glover (1972) showed that the administration of an
inhibitor of cholesterol biosynthesis to bile fistula rats
resulted in diminished secretion of bile acids which they
suggested was a consequence of decreased supply of substrate.
If this hypothesis is correct, then bile acid biosynthesis,
like cholesterol biosynthesis, will be regulated by the
amount of cholesterol which is absorbed from the gastro¬
intestinal tract as suggested by Dietschy and kilson (1970).
However Cayen (1971) showed that the incorporation into the
diet of tomatine, a steroid glycoside which complexes with
cholesterol in the small intestine and hence prevents
cholesterol absorption, significantly stimulated hepatic
cholesterologenesis without simultaneously affecting bile
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acid biosynthesis. This suggests that cholesterol bio¬
synthesis and degradation can be controlled independently
and that increased cholesterologenesis is not a sufficient
stimulus to cause induction of bile acid biosynthesis.
Other factors which control cholesterol biosynthesis
in rat liver are the amount ofcholestero1 in the diet and
the total caloric intake of the animal. Feeding a high
cholesterol diet markedly inhibits the activity of HMG CoA
reductase (Siperstein and Fagan 1966) and in the rat it
stimulates the formation of bile acids (Wilson 1962). The
activity of HMG CoA reductase is also reduced following
starvation (Hamprecht et al 1969). The effect of bile
acid absorption in controlling hepatic cho1esterologenesis
is under dispute. Weis and Dietschy (1969) suggested that
the ability of bile acids to inhibit hepatic HMG CoA
reductase in vivo could be explained in terms of their
effect on increasing the intestinal absorption of cholesterol.
However Hamprecht et al (1971) have challenged this by
showing that cholic acid feeding inhibited hepatic HMG CoA
reductase activity in rats with a lymph fistula where the
amount of cholesterol reaching the liver from the intestine
should be greatly reduced. It is difficult to correlate
these results with Cayen's results on tomatine feeding
where inhibition of cholesterol absorption without effect
on bile acid absorption was accompanied by a dramatic
increase in the rate of hepatic cholesterologenesis from
ac etate.
Cholesterol 7 -hydroxylase activity was studied under
different conditions which are known to affect the rate of
hepatic cholesterol biosynthesis in order to understand
more about the interrelationships between the regulation
of these two systems.
B. The effect of diet on cholesterol 7 <*. -hydroxylase
Control diets used in the animal unit of this depart¬
ment are a pellet diet (•Oxoid* No. 86) and a semisyntheti
soft diet (described in Section 2). Prior to Octcber 1971,
animals fed on either of these diets did not differ sig¬
nificantly in the activity of their liver microsomal
cholesterol 7o<. -hydroxylase (approximately 1-2fo conversion
of added substrate per hour). However, animals killed
after this date which had been fed on pellet diet were
found to have considerably greater cholesterol 7 DC. -hydroxy
lase activities (4-7^ conversion of added substrate per
hour). To establish that this effect was due to the diet
rather than to any seasonal variation in enzyme activity
or change in the animals, a group of rats were maintained
on the soft diet for four weeks. These were killed and
their liver microsomal cholesterol 7c* -hydroxylase
activities compared with a group which had been maintained
on the pallet diet. The results of this experiment are
shown in Table 3.
Cholesterol 7c* -hydroxylase activities were signifi¬
cantly greater in animals fed the pellet diet, suggesting
that some alteration in the composition of this diet coi^ld
be responsible for the effect. Consultation with 'Oxoid'
on this matter failed to resolve the issue. The only
suggestion they could offer was that since 1969 dieldrin
had no longer been used to spray the grain used in making
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Table 3
The effect of diet on rat liver cholesterol 7c< -hydroxylase
activity






1.9 - 0.3 4.4 - 0.7 P< 0.02
n = 4 n = 4
n = no. of animals in each group.
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the diet. Dieldrin is a polychlorinated insecticide vhich
has been shown to induce the activity of the drug metabol¬
ising enzymes of rat liver (Ghazal et al 1964). It seems
unlikely that removal of this compound could result in
increased activity of cholesterol 7 -hydroxy las e , however.
As discussed in Section 5, alterations in hepatic cytochrome
P450 levels do not seem to reflect changes in cholesterol
7 o<-hydroxylase activity.
Bile acid metabolism is known to be affected by the
integrity of the enterohepatic circulation; agents which
bind bile salts in the small intestine cause increased
secretion of bile salts from the liver. Normal constituents
of any diet probably adsorb bile salts to a certain extent.
Berafin and Nesheim (1970) showed that undigested protein
material in the gastrointestinal tract of chickens fed
soyabean meal bound bile salts and increased the rate of
turnover of bile acids. Eastwood and Hamilton (1968)
showed that a constituent of vegetable fibrous tissue
bound bile acids and salts. They established that the
fraction responsible was lignin, a structural aromatic
polymer having functional groups which may or may not be
methylated. The adsorption was abolished in the presence
of 6M urea and postulated to be hydrophobic in nature.
•Oxoid' No. 86 pellets contain approximately 3by weight
of crude fibres which come from grain and probably contain
lignin. It is possible that the structure of the lignin
in these fibres might vary according to the conditions
under which the grain is grown and hence alter the capacity
to adsorb bile salts. This would in turn alter the activity
of the cholesterol 7<* -hydroxylase.
Another factor vhich might affect bile acid metabolism
is the intestinal flora (Section 1). Dietary effects might
be secondary to changes in bacterial action. N.B. Anti
biotics have never at any time been incorporated into
'Oxoid* diets.
Whatever the explanation for the increase in enzyme
activity, it is evident that dietary composition plays a
major part in the regulation of bile acid metabolism. In
all subsequent experiments animals vere fed the soft diet
for at least four weeks prior to treatment.
C. The effect of Cholestyramine Feeding on Cholesterol
7 o< -Hydroxylase
Cholestyramine is an anionic exchange resin which binds
bile salts in the gut. The effect of this agent on liver
weight, microsomal protein content and cholesterol 7oC -
hydroxylase activity as measured by both assays is shown
in Table 4.
The treatment significantly increased the activity of
cholesterol 7-hydroxylase by three to four-fold as
measured by both methods. Liver weight and microsomal
protein content were not affected.
D. The effect of Cholesterol Feeding
Feeding a high cholesterol diet is known to increase
the total cholesterol level in rat liver, the excess being
mainly in the form of cholesterol esters (Gould 1955).
Fig. 15 confirms this effect on the animals used in these
experiments. The experimental group received a diet
containing 1$ (w/w) of cholesterol. Total cholesterol
Table 4
The effect of cholestyramine treatment on rat liver
cholesterol 7 t*> -hydr oxylas e activity
Control Cholestyramine Difference




n (mg/g 12.9 i 1.5 11.4 - 2.0 N.S.
a>
h ™ conversion to






SI Paoles/minut./ 14.0 ± 39.9 ± 9.0 P < 0.o,
u raS protein
t-
n = 8 n = 8
N.S. not significant,
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DAYS OF FEEDING DIET
Figure 15 The effect of cholesterol feeding on total liver
cholesterol content.
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was measured by the Liebermann-Burchardt reaction. The
hepatic cholesterol level increased to approximately
three times the control and appeared to stabilise after
4-5 days. In the rat a high cholesterol diet leads to
inhibition of hepatic cholesterologenesis and increased
bile acid production (Siperstein and Pagan 1963; Vilson
1962). The effect of feeding a high cholesterol diet on
cholesterol 7ot-hydroxylase activity is shown in Table 5.
The specific activity of the enzyme was measured by the
GLC method. These results show that cholesterol feeding
significantly increased the specific activity of the enzyme.
Total microsomal cholesterol levels were also increased by
about 30$ as measured by GLC. Liver weight and microsomal
protein content were not affected.
E. The effect of starvation on Cholesterol 7o<-Hydroxylase
The starved animals in this experiment were kept without
food for 48 hours. Table 6 shows the effect of this treat¬
ment on liver weight, microsomal protein content and liver
microsomal cholesterol 7o< -hydroxylase . These were all
significantly reduced by starvation. The effect on liver
weight and microsomal protein content means that the
decreased production of 7ot -hydroxycho1estero1 per liver
is even more marked than is suggested by the decrease in
specific activity of the enzyme.
E• The effect of biliary drainage in the starved rat
Starvation markedly inhibits the activity of hepatic
HMG CoA reductase, the major rate limiting enzyme in
cholesterol biosynthesis. Starved animals were subjected
to biliary drainage in order to determine whether cholesterol
43
Table 5






Liver weight (g) 8.5 - 1.2 9.3 - 0.8 N.S.
Microsomal protein
(mg/g liver)




12.4 - 1.7 18.0 t 0.8 P < 0.05
Microsomal choles¬
terol (pg/g liver)
208 - 29 268 ± 43 P < 0.01
n = 8 n = 8
N.S. not significant
n = no. of animals in each group.
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Table 6
The effect of starvation for 48 hours on rat liver
cholesterol 7o<. -hydroxylase activity
Control .Starved Diff erence
Liver weight (g) 9.9 - 0.5 7.3 - 1.2 P < 0.01
Microsomal protein
(mg/g liver)





16.6 ± 2.2 5.8 ~ 0.7 P < 0.001
n = 4 n = 4
n m no. of animals in each group.
Table 7
The effect of biliary drainage in the starved rat . The
animals were starved :Cor 72 hours and bile duet-cannulated




Liver weight (g) 4.5 - 1.0 6.0 - 1.0 N.S.
Microsomal protein





5.6 t 2.1 16.1 - 4.8 P < 0.05
n ss 6 n = 6
N.S. not significant




















IN THE STARVED RAT
(P<0 05 )
(6,)&)
Figure 16 The effect of different in vivo treatments on
cholesterol 7oL -hydroxylase activity in vitro.
Hatched histograms are experimental, blank are
controls. The number of animals in each group
is shown in parentheses.
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7 <A -hydroxylase activity could be induced under conditions
in which cholesterol synthesis is inhibited. Animals were
kept without food throughout the experiment. After 24
hours one group was subjected to bile duct cannulation and
another group was sham operated. After 72 hours the animals
were killed and liver microsomal cholesterol 7o<-hydroxylase
activities measured. The results are shown in Table 7.
Biliary drainage significantly increased cholesterol 7oC -
hydroxylase activity in the starved rat.
The effects of cholestyramine feeding, cholesterol
feeding, starvation and biliary drainage plus starvation
are summarised in Fig. 16.
G. The effect of Tomatine Feeding on Cholesterol Biosynthesis
and Cholesterol 7<* -Hydroxylase
Cayen (1971) showed that the incorporation into the
diet of tomatine, a steroid glycoside which complexes vith
cholesterol and when fed prevents cholesterol absorption,
significantly increases the rate of hepatic cholesterol
biosynthesis without simultaneously affecting bile acid
biosynthesis. This suggests that these two pathways are
controlled independently. The effect of tomatine on rat
liver cholesterol 7(A -hydroxylase was investigated. The
agent was administered at 1% in the diet for one week and
cholesterol 7o(. -hydroxylase and cholesterol biosynthesis
from acetate were measured. The results were compared
with the effect of cholestyramine on these systems and are
shown in Tuble 8.
Tomatine feeding significantly increased cholesterol
biosynthesis from acetate but had no effect on cholesterol
14


































N.S.notsignificant n=o.ofanimalsi eachgroup (
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7oC-hydroxylase, whereas cholestyramine activated both of
these systems. Tomatine seems to have a similar effect to
digitonin in complexing with cholesterol^ however it is
non-toxic in that the complex is not adsorbed. The animals
showed normal weight gain and there was no effect on total
liver weight or microsomal protein content. Neither
tomatine nor cholestyramine had any effect on microsomal
cholesterol levels. In the former case increased choles¬
terol biosynthesis is compensated for by increased excretion
of neutral steroids and in the case of the latter by
increased bile acid production. The results show that
increased cholesterol synthesis per se is not sufficient
to stimulate the formation of 7 -hydroxycholesterol.
Summary to Section 4
(1 ) Rat liver cholesterol 7oC -hydroxylase activity was
influenced by the type of diet on which the animals were
maintained. Rats fed on the pellet diet had significantly
greater enzyme activities than those fed on the semi¬
synthetic soft diet.
(2) Cholesterol feeding significantly increased the
activity of rat liver cholesterol 7 ot -hydroxylase.
(3) Starvation significantly reduced cholesterol 7oC -
hydroxylase activity.
(4) When starved animals were subjected to biliary
drainage liver microsomal cholesterol 7o< -hydroxylase
activity was significantly increased over controls.
(5) Tomatine feeding significantly increased hepatic
cholesterol biosynthesis from acetate without affecting
cholesterol 7<A -hydroxylase, whereas cholestyramine
feeding activated both of these systems.
SECTION 5
CHOLESTEROL 7c< -HYDROXYLASE AS A LIVER MICROSOMAL
MIXED FUNCTION OXIDASE
A. Introduc tion
Rat liver microsomal cholesterol 7o(. -hydroxylase is a
mixed function oxidase requiring molecular oxygen and NADPH
The terminal oxidase for this reaction is cytochrome P450,
as shovn by the inhibition by carbon monoxide vhich is
reversed by monochromatic light at 450 nm (Boyd et al 1971)
Cytochrome P450 is reduced by NADPH, this reduction being
mediated by a flavoprotein. Other compounds vith a suitabl
redox potential can accept electrons from the reduced flavo
protein, for example cytochrome c, and in fact this flavo-
protein was discovered as an NADPH cytochrome c reductase
(Horecker 1950). There is considerable evidence that this
flavoprctein participates in the reduction of cytochrome
1450 in mixed function oxidations. These cytochrome P450-
dependent hydroxylations are inhibited by cytochrome c,
which presumably competes with cytochrome P450 for electron
from the reduced flavoprotein (Oshino et al 1968). Certain
microsomal hydroxylase activities can be reconstituted by
partially purified preparations of cytochrome P450 and
flavoprotein (Lu and Coon 1968). An antibody prepared
against the flavoprotein, NADPH cytochrome c reductase, was
shown to inhibit cytochrome P450-dependent mixed function
oxidase activity (Masters et al 1971). There is at present
no evidence for the participation of any other electron
transferring component in the reduction of cytochrome P450
in liver microsomes. In some tissues, for example adrenal
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cortex mitochondria, the transfer of electrons from the
flavoprotein to cytochrome P450 is mediated by a non-haem
iron protein; however there is no evidence for any
involvement of non-haem iron in the reduction of liver
microsomal cytochrome P450 by NADPH.
The liver microsomal mixed function oxidase system
catalyses the oxidation of drugs, carcinogens and steroids
and can be induced by the administration of certain oxidi-
sable substrates. This induction mechanism appears to be
non-specific as phenobarbitone treatment results in an
increase in the activity of the enzymes which metabolise
not only phenobarbitone but also a large number of other
substrates (review by Conney 1967). The induction of
enzyme activity is accompanied by an increase in the content
of cytochrome P450 and also the activity of NADPH cytochrome
c reductase, suggesting that these components might be rate-
limiting in the overall hydroxylation mechanism (Orrenius
et al 1965). Present evidence suggests that there are two
forms of cytochrome P450, one form with the haem iron in
the high spin state which is induced by 3-methylcholanthrene
tre atment,and a low spin form which is induced by pheno¬
barbitone (Hildebrandt et al 1968). The formation of
difference spectra on the addition of an oxidisable sub¬
strate to oxidised microsomal suspensions (Remmer et al
1966; Schenkman et al 1967a) suggests that cytochrome P450
is the substrate binding site, and studies by Lu et al
(1972) suggest that the difference in specificity of the
hydroxylases induced by phenobarbitone and 3-methylcholan¬
threne is due to the haemoprotein moiety
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Cholesterol 7 c< -hydroxylase appears to differ from the
other liver microsomal cytochrome P450-dependent mixed
function oxidases in that the enzyme induction vhich occurs
following biliary diversion is not accompanied by a simul¬
taneous increase in the liver content of cytochrome P450
(Boyd et al 1969), suggesting that this cytochrome is not
rate-limiting in cholesterol hydroxylation. The effect of
phenobarbitone treatment on cholesterol 7c* -hydroxylase is
under dispute. Einarsson and Johansson (1968b) and Boyd <et
al (1969) could show no significant effect, whereas Shefer
et al (1968) reported a several-fold stimulation.
However a recent report suggests that this discrepancy may
be due to the difference in the strain of rats used (Shefer
et al 1972).
This section concerns experiments vhich investigate
the relationship of cholesterol 7oC -hydroxylase to the rat
liver microsomal mixed function oxidase system which
hydroxylates drugs. In some experiments the enzyme
aminopyrine demethylase has been studied for comparative
purpos es.
B• Cholestyramine Treatment
The effect of cholestyramine treatment on cholesterol
7ot-hydroxylase, NADPH cytochrome c reductase, cytochrome
P450 and aminopyrine demethylase is shown in Table 9.
Although cholesterol 7<* -hydroxylase activity was signifi¬
cantly increased by this treatment, there was no effect on
aminopyrine demethylase activity or on the components of
the electron transport system cytochrome P450 or NADPII
cytochrome c reductase.









Figure 17 The effect of aminopyrine on cholesterol 7 c* -
hydroxylase in vitro.
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C. The Effect of Aminopyrine on Cholesterol 7oc -Hydroxylase
1 in Yitro1
Tephly and Mannering (1968) showed that steroids
competitively inhibit the microsomal oxidation of drugs
such as ethylmorphine and hexobarbital and Orrenius and
Thor (1969) showed that laurate competitively inhibits the
oxidation of ethylmorphine. These results suggest that
those compounds which undergo oxidation by cytochrome P450
compete for the same binding site on the enzyme. Pig. 17
shows the effect on cholesterol 7 oC -hydroxy las e of incubating
microsomes in the presence of aminopyrine. The activation
of cholesterol 7o<, -hydroxylase by aminopyrine is difficult
to explain, but suggests that the drug does not bind at the
same binding site on cytochrome P450 as cholesterol.
D. Phenobarbitone Treatment
The effect of administering phenobarbitone to rats for
one week is shown in Table 10. Liver weight and microsomal
protein content were significantly increased by the treat¬
ment in agreement with the results of Orrenius et al (1965).
Although cytochrome P450 content was increased by approxi¬
mately three-fold, there was no effect on the specific
activity of cholesterol 7<* -hydroxylase. However there
was an increase in the level of the enzyme when calculated
on the basis of total liver weight. Phenobarbitone treatment
has a similar effect on the liver microsomal enzyme nucleoside
diphosphatase (Orrenius et al 1969).
E. 3-Methylcholanthrene Treatment
3-Methylcholanthrene is a polycyclic hydrocarbon which
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Table 10 The effect of phenobarbitone treatment
„ , , Phenobar- „
Control . , , Difference
bitone
Liver weight (g) 11.3 -f 2.0 15.1
+











0.13 P < 0.001
r-f <D
2 g (pmoles/min/
















n == 8 n = 8
N.S. not significant
n = no. of animals in each group.
Table 11 The effect of 3-methylcholanthrene treatment
Control Difference
cholanthrene


































n = 4 n = 4
N.S. not significant
n = no. of animals in each group.
■ CYTOCHROME PA50
x AMINOPYRINE DEMETHYLASE
o NAOPH - CYTOCHROME C REDUCTASE
•CHOLESTEROL-70c-HYDROXYLASE
DAYS OF STORAGE AT- 10°C
figure 18 The effect of storing rat liver microsomes
-10°C on enzyme activity.
54
induces a form of rat liver cytochrome P450 which is in
the high spin state (Section 1).
Table 11 shows that although this agent significantly
induced microsomal cytochrome P450 levels, it had no effect
on cholesterol 7o0-hydroxylase activity. In contrast to
phenobarbitone treatment, there was no increase in liver
weight or microsomal protein content and hence the total
level of enzyme per liver did not alter.
P. The Effect of Starvation
In Section 4 (Table 6) it was shown that starvation
of animals for 48 hours significantly reduced the specific
activity of cholesterol 7oO-hydroxylase. This treatment
significantly decreased liver weight and microsomal protein
content, but there was no change in the cytochrome P450
content per g of liver, hence the amount of cytochrome P450
per mg of microsomal protein was increased.
The effect of different in vivo dietetic regimens and
treatments on in vitro liver microsomal cholesterol 7oC -
hydroxylase activity and cytochrome P450 levels is summarised
in Table 12, and shows the lack of correlation between these
two enzymic parameters.
G-. Storage of Liver Microsomes at -10°C
Conney et al (1969) showed that storage of rat liver
microsomes in the deep freeze had a differential effect on
the activity of testosterone hydroxylation at positions
6^,, 7 oO and 16 cd . Vhereas there was a progressive decrease
in 6^ and 16oC -hydroxylation which took place over several
weeks, the 760 -hydroxylase activity remained stable.
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Table 12
Relationship between cytochrome P450 levels and cholesterol
7 c^-hydroxylase
Cytochrome P450 Cholesterol-7o(. -
Treatment hydraylase
nraoles/mg protein pmoles/min/mg protein
Control 0.35 - 0.07 14.0 ± 1.5
Cholestyramine
4JS in diet 0.37 - 0.03 39.9 - 9.0*
3-methyl cholanthrene
20 mg/kg i.p. 0.84 ± 0.02* 15.0 t 3.7
for 3 days
Phenobarbitone
1 mg/ml in drinking 1.30 i 0.13* 15.4 i 2.0
water for 6 days
Starvation for 48 hrs. 0.60 i 0.03* 5.8 i 0.4*
*p < 0.001.
TIME (HOURS)
Figure 19 The effect of eyeloheximide treatment on enzyme
activity. The animals were given a single
injection at 9.00 a.m. according to the procedure
described in Section 2, part E.
The effect of storing rat liver microsomes for several
days at -10°C is shown in Fig. 18. Cholesterol 7c>( -
hydroxylase was very labile to this treatment, the activity
being reduced by approximately 50% after several days,
whereas aminopyrine demethylase, NADPH cytochrome c
reductase and cytochrome P450 remained stable.
H. Cycloheximide Treatment
The effect of cycloheximide treatment on cholesterol
7c*-hydroxylase, aminopyrine demethylase, cytochrome P450
and NADPH cytochrome c reductase is shown in Fig. 19. The
dose of cycloheximide administered (5 mg/kg)is sufficient
to inhibit the translation of messenger RNA into protein
in rat liver by approximately 95> for 6 hours without
having much effect on nuclear RNA synthesis (Harris et al
1969). Hence the time course of the enzyme activities
following this treatment should give a measure of the rate
of degradation of the enzyme in vivo. As shown in Fig. 19,
cholesterol 7 di -hydroxylase activity decayed more rapidly
than the other three enzymes studied, the half-life being
approximately 3 hours. This value is in agreement with
that reported by Einarsson and Johansson (1968a) who found
that cholesterol 7cA -hydroxylase activity decayed with a
half-life of 2-3 hours following puromycin treatment.
Cycloheximide had no effect on rat liver microsomal
cholesterol 7 c* -hydroxylase in vitro .
Levin and Kuntzman (1969) showed that the radioactivity
3
incorporated into 'CO-binding particles' from (3,5- H) 6-
aminolaevulinic acid (a precursor of the haem moiety)
decayed biphasically, the half-lives of the two components
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being 7 hours and 48 hours. They equated these two com¬
ponents with low spin cytochrome P450 and high spin
cytochrome P450 respectively. In this experiment the
measurements of cytochrome P450 following eye 1oheximide
treatment were made over a period of only 6 hours so that
a biphasic effect would not be observed.
These studies show that cholesterol 7o< -hydroxylase
decays more rapidly after cycloheximide treatment than
does the drug hydroxylase aminopyrine demethylase, or the
components of the hydroxylation system cytochrome P450 and
NADPH cytochrome c reductase.
I • The Effect of Preincubating (4-^C) Cholesterol with
1 4
Rat Liver Microsomes on the Formation of (4- C)
7d -Hydroxycholesterol
The above experiments suggest that although cytochrome
P450 may be the terminal oxidase for cholesterol 7o(. -
hydroxylase, it does not appear to be rate-limiting. The
cholesterol side chain cleavage enzyme of adrenal cortex
mitochondria is also a mixed function oxidase having
cytochrome P450 as the terminal electron acceptor (Simpson
and Boyd 1967). The activity of this enzyme is stimulated
by ACTH and the activation is not accompanied by an increase
in the amount of cytochrome P450. Evidence has accumulated
which suggests that this enzyme may be regulated by the
amount of substrate cholesterol which is bound to the
cytochrome P450 and this is in turn regulated by a
cycloheximide sensiti.ve factor which has a half-life of
several minutes (Simpson et al 1972; Jefcoate et al 1972;
Grarren et al 1965). It is conceivable that a similar type
<
1 4
Figure 20 The effect of pre incubating (4- C) cholesterol
vith liver microsomes on the formation of (4-^C)
7o(, -hydroxycholesterol.
of control mechanism might exist for cholesterol
hydroxylation in liver microsomes.
If the rate of cholesterol binding to the enzyme in
liver microsomes is a slow step, as it appears to be in
adrenal cortex mitochondria, then preincubation of radio¬
active cholesterol with liver microsomes prior to starting
the reaction with NADPH should increase the conversion to
radioactive 7c(, -hydroxycholestero 1. This has been demon¬
strated for cholesterol conversion to pregnenolone in
adrenal cortex mitochondria and was interpreted as
indicating a slow binding of substrate to the enzyme
system (Simpson et al 1972).
1 4
The effect of preincubating (4- C) cholesterol with
liver microsomes on the formation of (4-^C) 7o< -
hydroxycholesterol is shown in Fig. 20. Liver microsomes
were preincubated for 10 minutes with radioactive choles¬
terol before adding NADPH generator. Controls were pre¬
incubated with the same volume of acetone and radioactive
cholesterol was added at the same time as the NADPH
generator. The percentage conversion of radioactive
cholesterol to radioactive 7c<. -hydroxycholesterol was
consistently greater in the preincubated group. To
determine if this difference was statistically significant,
groups of samples were preincubated for 10 minutes and the
reactions were stopped 50 minutes after the addition of
NADPH generator. The results are shown in Table 13 for
liver microsomes obtained from a cholestyramine treated
rat and from a control rat. Preincubation of the micro¬
somes with the radioactive cholesterol caused significantly
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Table 13
The effect of preincubating (4-^C) cholesterol with liver
microsomes on the formation of (4-^C) 7o< -hydroxycholesterol








Soft 1.24 - 0.02
diet (n = 5)
Cholesty- 6.62 - 0.13










n = no. of animals in each group.
greater conversion to radioactive product in each case, but
the difference appeared to be greater with microsomes from
the cholestyramine treated rat.
These results suggest that formatinn of enzyme-
cholesterol complex is a slow step and that preincubation
allows the radioactive substrate to equilibrate with a
small pool of endogenous cholesterol which is closely bound
to the enzyme. This hypothesis is not inconsistent with
the results of Section 3, part P, which indicated that the
radioactive cholesterol equilibrated immediately with all
the endogenous substrate. The increase in percentage
conversion of radioactive cholesterol which is produced by
preincubation is less than 0'5ftf which would correspond to
less than 1 ;ug of endogenous cholesterol. Prom the results
of Section 3 (part E), it is unlikely that the degree of
precision of the two assays would be great enough to detect
this difference. Preincubation for longer than 10 minutes
did not significantly increase the formation of (4-^C)
7 o(.-hydroxycholesterol. The half-time for complete
equilibration was estimated to be of the order of 5 minutes.
If formation of cholesterol-enzyme complex in liver
microsomes is a slow step, as these results suggest, then
this step could be rate limiting in cholesterol 7<X -
hydroxylation. This could be the step which is enhanced
by cholestyramine treatment and which is cycloheximide
sensitive and labile to freezing and thawing. This is
discussed in greater detail in Section 7.
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Summary to Section 5
(1) Cholestyramine feeding stimulated cholesterol 7c* -
hydroxylase activity without affecting cytochrome P450
concentrations, NADPH cytochrome c reductase activity or
the rate of demethylation of the drug, aminopyrine.
(2) Aminopyrine activated liver microsomal cholesterol
7 oC -hydroxylas e in vitro, activation being half-maximal
at approximately 1 mM.
(3) Phenobarbitone treatment (1 mg/ml in the drinking
water for one week) increased the concentration of liver
microsomal cytochrome P450, but had no effect on the
specific activity of liver microsomal cholesterol 7c* -
hydroxylase. However, the total activity of cholesterol
7 -hydroxylase per liver was significantly increased by
this treatment.
(4) 3-Methylcholanthrene treatment (20 mg/kg body weight
for three days) increased the concentration of liver
microsomal cytochrome P450 but had no effect on the specific
activity of cholesterol 7oC -hydroxylase or on the total
activity of the enzyme in the liver.
(5) Starvation for 48 hours significantly increased the
content of hepatic cytochrome P450 per mg of microsomal
protein but decreased the specific activity of liver
microsomal cholesterol 7ot -hydroxylase.
(6) Storage of liver microsomes at -10°C for several days
resulted in approximately 50fo reduction of liver microsomal
cholesterol 7-hydroxylase activity, but cytochrome P450,
NADPH cytochrome c reductase and aminopyrine demethylase
remained stable to this treatment.
(7) Cycloheximide treatment (a single injection at a
dose of 5 mg/kg body weight) resulted in a rapid decay
of cholesterol 7<*> -hydroxylase activity (half-life
approximately 3 hours). Cytochrome P450, NADPH cytochrome
c reductase and aminopyrine demethylase decayed at slower
rates.
(8) Pre incubating liver microsomes with (4-^C) choles¬
terol for 10 minutes prior to starting the reaction with
NADPH resulted in a significantly greater production of
(4-^C) 7 oC.-hydroxycholestero 1. This suggests that the
binding of substrate cholesterol with the enzyme is a
slow step.
SECTION 6
THE SPECIFICITY OF THE RAT LIVER MICROSOMAL
CHOLESTEROL 7<* -HYDROXYLASE
A. Introduction
The results reported in Section 5 show that there are
certain important differences between cholesterol 7o( -
hydroxylase and aminopyrine demethylase. Although both of
these enzymes require cytochrome P450 as the terminal
oxidase, they appear to be regulated by different
mechanisms in vivo. One possible explanation is that the
rate of cholesterol hydroxylation is not limited by the
amount of cytochrome P450 in the liver, but by another
component which is specific for cholesterol. This could
be a carrier protein for transporting substrate cholesterol
to the oxygen activating site. Sterol carrier proteins
have been implicated in hepatic cholesterol biosynthesis
(Ritter and Pempsey 1971; Scallen et al 1971). The liver
microsomal mixed function oxidase system is non-specific
and from a teleological viewpoint it seems reasonable that
different mechanisms should have evolved for the control
of bile acid biosynthesis and the oxidation of foreign
compounds. It is therefore of interest to establish the
degree of specificity of the cholesterol 7ck -hydroxylase
enzyme.
This section concerns studies which have been made on
the oxidation of certain steroid substrates and cholesterol
by liver microsomes in the presence of NADPH and oxygen.
The substrates chosen for study were the androgen




















Figure 21 Radioactive scans of thin layer plates of the
lipid extracts obtained after incubation of
1 4
liver microsomes with (A) (4- G) dehydroepian-
drosterone, (B) (4-^C) pregnenolone, (C) (^H)
androst-5-ene-3 -ol, (D) ( H) pregn-5-ene-3 (*> -o 1.
Figure 22 The effect of substrate concentration on the
rate of dehydroepiandrosterone oxidation.




Figure 23 Time course for dehydroepiandrosterone oxidation.
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hormone biosynthesis pregnenolone, and the ketone reduction
products of these, androst-5-ene-3 Q> -ol and pregn-5-ene-3 Q> -ol
respectively. These compounds have the same steroid nucleus
as cholesterol (Fig. 1) but differ in the structure of the
side-chain.
B. The Metabolism of Dehydroepiandrosterone, Pregnenolone,
Androst-5-ene-3 -ol and Pregn-5-ene-3 6 -ol by Rat
Liver Microsomes
Thh patterns of products obtained after TLC of the lipid
extracts from incubations of the radioactive steroids with
liver microsomes, NADPH and oxygen are shown in Fig. 21.
No products were obtained when NADPH was excluded from the
incubation medium or when the incubations were conducted
under an atmosphere of nitrogen. No products were formed
when boiled microsomes were used in the incubations. The
oxidation of each of these steroids will now be considered
individually.
C. The Oxidation of Dehydroepiandrosterone
The metabolism of dehydroepiandrosterone by rat liver
microsomes has been studied by Sulcova and Starka (1968)
who reported the formation of the 7 -hydroxylated epimers,
and by Heinrichs and Colas (1968) who reported in addition
the formation of the 16 c* -hydroxylated product. These
workers employed colorimetric methods to measure product
formation.
The pattern of products obtained following incubation
1 4
of (4- C) dehydroepiandrosterone with rat liver microsomes










These have been tentatively identified as the 16o( , 7and
7-hydroxylated steroids (in decreasing order of Rf value)
by comparing their behaviour on TLC in different solvent
systems with the standard referencecompounds. The major
metabolite was the 7 at. -hydroxylated steroid, and the
characteristics of its enzymic formation have been
inves tigated.
Fig. 22 shows that the enzyme was half-saturated when
the substrate concentration was approximately 25 31M. The
reaction was first order with respect to microsomal
protein concentration (Fig. 24) and was linear for
approximately 15 minutes at 37°C (Fig. 23).
The inclusion of 10 mM (*>-mercaptoethylamine in the
incubation medium did not affect the formation of any of
the products of dehydroepiandrosterone metabolism. As Q, -
mercaptoethylamine inhibits the formation of 'autoxidation
products' of cholesterol and lipid peroxides by liver
microsomes (Grimwade et al 1971 ), this suggests that the
products of dehydroepiandrosterone metabolism are not
formed by a peroxidative mechanism. Carbon monoxide was
found to markedly inhibit the formation of all three
products, implicating the involvement of cytochrome F450
in the hydroxylation mechanism.
D. The Oxidation of Pregnenolone
Starka et al (1966) reported that pregnenolone was
hydroxylated in the 7ci -position by rat liver microsomes
in the presence of NADPH and oxygen. The pattern of
1 4
products obtained when (4- C) pregnenolone was incubated




Figure 25 The effect of substrate concentration on the
rate of pregnenolone oxidation.
Microsomal protein concentration »
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Figure 27 The effect of microsomal protein concentration
on pregnenolone oxidation.
Substrate concentration, 1 50 incubation time, 15 minutes.
Figure 28 The effect of substrate concentration on the
rate of androst—5—ene—3 ^—o1 oxidation.
gure 29 Time course for androst-5 -ene-3 ^ -ol oxidation.
Microsomal Protein (mg/ml)
Figure 30 The effect of microsomal protein concentration
on and.rost-5-ene-3 <>» -o 1 oxidation.
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When the major product was rechromatographed in different
solvent systems it failed to resolve into more than one
peak. When (7<* - H) pregnenolone was used instead of
(4-^C) pregnenolone there was no loss of tritium,
suggesting that this product is not the 7c< -hydroxylated
derivative, however it has not been identified. The rate of
formation of this product was half-maximal at a substrate
concentration of approximately 50 jiM as shown in Fig. 25.
The reaction rate was linear for approximately 15 minutes
at 37°C (Fig. 26) and was first orderwith respect to
microsomal protein concentration (Fig. 27). Product
formation was not affected by ^-mercaptoethylamine
suggesting that a peroxidative mechanism was not involved.
E. The Oxidation of Androst-5-ene-3 Cb -ol
11 1 1 I.. 1 H
Further chromatography of the product obtained from
the liver microsomal metabolism of this steroid (Fig. 21C)
failed to resolve it into more than one peak, however this
compound has not been identified. The enzyme was half-
saturated at a substrate concentration of approximately
40 yiM (Fig. 28). The time course for the reaction at 37°C
is shown in Fig. 29 and the effect of microsomal protein
concentration in Fig. 30. As with the previous two steroid
substrates discussed, the product formation was not
affected by (^-mercapt oethylamine .
F. The Oxidation of Pregn-5-ene-3 C> -ol
This steroid was metabolised to at least four products
when incubated with liver microsomes, NADPH and oxygen
(Fig. 21D). None of these have been positively identified.
Figure 31 The effect of substrate concentration on the
rate of pregn—5 — ene—3 (£, — o 1 oxidation.
Figure 3 2 Time course for pregn-5-ene-3^ -o1 oxidation.
Substrate ,-.onoentration 75
Microsomal Protein (mg/ml)
Figure 33 The effect of microsomal protein concentration
on pregn—5—ene—3 (£> — o 1 oxidation.
Substrate concentration 75
Incubation time 15 minutes.
Figure 34 The effect of (*> -mercaptoethylamine on pregn-5-
ene-3f>,-ol oxidation in vitro.
The formation of the major product (Rf = 0*48, Fig. 213)
was investigated. The reaction was half-saturated at a
substrate concentration of approximately 15 /uM (Fig. 31).
The time course for the reaction is shown in Fig. 32 and the
effect of increasing microsomal protein concentration in
Fig. 33. The formation of all products was found to be
markedly inhibited by incorporating Q-mercaptoethylamine
into the incubation medium. Fig. 34 shows the effect of
increasing the concentration of this thiol on the formation
of the major product. This suggests that pregn-5-ene-3 Q-o1
might be oxidised by a peroxidative mechanism, similar to
the formation of 7-ketocho1estero1 from cholesterol which
is also inhibited at the same concentrations of Q-mercap-
toethylamine (Mitton et al 1971).
G-. The Binding of Dehydroepiandrosterone, Pregnenolone,
Androst-5-ene-3fe-ol and Fregn-5-ene-3 -o1 to Rat
Liver Microsomes
Substrates for the cytochrome P450-dependent mixed
function oxidase system of liver microsomes produce a
characteristic difference spectrum when added to oxidised
suspensions of liver microsomes (Section 1). The steroid
substrates whose oxidative metabolism has been studied
were tested for the production of difference spectra with
rat liver microsomes.
Type I difference spectra were produced by dehydro-
epiandrosterone, pregnenolone, and androst-5-ene-3(J-o1,
but pregn-5-ene-3 -ol gave no difference spectrum. The
binding constants (Ks) for these steroids are given in
Table 14.
Table 14
The binding of sterols to liver microsomal cytochrome P450
Sterol Ks^M)
Dehyd.roepiand.ro sterone 0.96 -0.10
Pregnenolone 1 .16 i 0.10
Androst-5-ene-3^ -ol 0.73 - 0.05
Pregn-5-ene-3 (*> -ol
Figure 3 5 The effect of (A) dehydroepiandrosterone,
(B) pregnenolone, (C) androst-5-ene-3 $-ol
and (D) pregn-5-ene-3 -ol on cholesterol
7c< -hydroxylase in vitro.
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This suggests that the oxidation of the former three
steroids might involve cytochrome P450 and that the oxida¬
tion of pregn-5-ene-3 (Js-o 1 may be peroxidative as it is
inhibited by (b-mereaptoethylamine.
H. The Effect of Dehydroepiandrosterone, Pregnenolone,
Androst-5-ene-3ft -ol and Pregn-5-ene-3 ft -ol on
Cholesterol 7oC-Hydroxylase 'In Vitro*
Fig. 35 shovs the effect of these steroids on rat
liver microsomal cholesterol 7c*. -hydroxylase in vitro.
Dehydroepiandrosterone, pregnenolone and androst-5-ene-
3^—ol all inhibited, whereas progn-5-ene-3^-ol had no
effect at any of the concentrations tested.
Table 15 summarises some of the properties of these
steroids with respect to rat liver microsomes. Pregn-5-
ene-3(b-ol differs from the other three steroids in that
its oxidation is inhibited by ^-mercaptoethylamine and
that it does not inhibit cholesterol 7ol -hydroxylase or
form a Type I difference spectrum with liver microsomes.
I. The Effect of Cholestyramine Feeding on bteroid Metabolism
The effect of three of these steroids in inhibiting
cholesterol 7«A -hydroxylase suggests that they might be
metabolised by the same enzyme system. If this is so,
then cholestyramine feeding, which induces cholesterol
7-hydroxylase activity, should also stimulate the
oxidation of these steroids.
Table 16 shows the effect of cholestyramine treatment
on the oxidation of cholesterol, dehydroepiandrosterone,




Sterol_by10mMft—spectrumvi hli er7ot-hydroxylase,>niercaptoethylammemicrosomes Dehydroepiandrosterone Pregnenolone Androst-5-ene-3Q-o1 Pregn-5-ene-3(lol
—J
o













































N.S.otsignificant Dehydroepiandrosterone,preg enoloneda r st—5—ene—3Ql(150^iM)a dp egn-5 ne3̂- l(7JiM) vereincubat dfor15minutes37°C,d sc ibediSection2(PartR).
72
Cholesterol 70(. -hydroxylase was significantly stimulated,
however there was no effect on the rate of oxidation of
any of the other steroids tested. This suggests that these
steroids are metabolised by a different enzyme system from
cholesterol, or that there is a different rate determining
step. It is interesting to note that the rate of metabolism
of dehydroepiandrosterone, pregnenolone and androst-5-ene-
3 ^-ol is approximately two orders of magnitude greater
than cholesterol 7cA, -hydroxylase activity.
Summary to Section 6
(1) The metabolism by liver microsomes of four steroids
having the same ring structure as cholesterol (3Q -hydroxy,
5
A unsaturated; but differing in the structure of the side-
chain has been investigated. These are dehydroepiandrosterone,
pregnenolone, androst-5-ene-3 (^-ol and pregn-5-ene-3 (3 -ol
(Fig. 1).
(2) Dehydroepiandrosterone was metabolised to three
products, tentatively identified as the 7cA >7 Q> and 16 c*
hydroxylated derivatives. The rate of formation of the
major product, , 70^ -dihydroxyandros t-5-ene-1 7-one, was
investigated. The formation of all of these products was
inhibited by carbon monoxide.
(3) Pregnenolone was metabolised to at least one major
product which has not been identified.
(4) Androst-5-ene-3^ -o1 was metabolised to at least one
product which has not been identified.
(5) Pregn-5-ene-3 (i-o 1 was metabolised to at least four
unidentified products. The rate of formation of the major
product was investigated.
(6) The formation of all of these products required NADPH
and oxygen. The oxidation of dehydroepiandrosterone,
pregnenolone and androst-5-ene-3 Q> -o1 was not affected by
<^-mer capto ethylamine , but pr egn-5-ene-3 -o 1 oxidation
vas markedly inhibited by this thiol.
(7) Dehydroepiandrosterone, pregnenolone and androst-5-
ene-3Q>-ol formed Type I difference spectra with suspen¬
sions of liver microsomes, but pregn-5-ene-3 (£ -ol did not
form a difference spectrum.
(8) Dehydroepiandrosterone, pregnenolone and androst-5-
ene-3Q>-ol all inhibited cholesterol 7(A -hydroxylase
activity in vitro but pregn-5-ene-3 -o 1 had no effect.
(9) Rats fed cholestyramine experienced a marked
induction of liver microsomal cholesterol 7d- -hydroxylase
whereas there was no effect on the rate of oxidation of




The steady state concentration of total body choles¬
terol in mammals is governed by homeostatic mechanisms
which vary from species to species (review by Dietschy and
Wilson 1970). Most tissues have the capacity to synthesise
cholesterol but in the rat the liver accounts for approxi¬
mately 80°/o of the total body production (Dietschy and
Siperstein 1967). Cholesterol is excreted from the body
mainly in the form of bile acids and faecal neutral
sterols, each pathway accounting for approximately 50fo of
the total under normal conditions. On a sterol free diet,
the rates of cholesterol synthesis and catabolism are approxi¬
mately equal, but when cholesterol is supplied in the diet,
hepatic cholesterologeneais is inhibited. This regulatory
mechanism appears to operate in all species, control taking
place at the level of the enzyme HMG CoA reductase (Siperstein
and Pagan 1966). When the dietary intake is such that
inhibition of endogenous synthesis is not sufficient to
prevent total body cholesterol from increasing, other
regulatory mechanisms operate. In man, absorption from the
gastrointestinal tract is limited and suppression of hepatic
HMG CoA reductase activity is probably sufficient to
prevent a significant increase in whole body cholesterol
content. In the rat and in the dog, there does not appear
to be a limit on intestinal absorption, and excess dietary
cholesterol is compensated by increasing bile acid output.
Fig. 15 demonstrates that when rats were maintained on a
diet containing 1jf« cholesterol, the total liver cholesterol
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content increased by three-fold after four to five days,
until a new steady-state level was attained. This excess
is thought to occur mainly in the form of esterified
cholesterol,the free cholesterol level remaining constant
(Gould, 1955). The rabbit appears to lack the ability to
accelerate bile acid production in response to increased
cholesterol absorption, hence when this species is main¬
tained on a diet high in cholesterol, the total amount of
this sterol in the body increases indefinitely. Hence in
the rat and in the dog, bile acid synthesis is an important
regulatory mechanism in maintaining total body cholesterol
levels constant.
The demonstration by Eriksson in 1957 that the drainage
of bile from a bile fistula rat caused an.increase in the
rate of production of bile acids, led to the hypothesis
that bile acids control their own rate of synthesis. In
1967, Danielsson et al showed that biliary diversion was
accompanied by an increase in the activity of the choles¬
terol 7oC —hydroxylase enzyme. This discovery, plus the
fact that no intermediate in the pathway of cholesterol to
bile acids accumulate to any extent in the liver, suggested
that 7c*-hydroxycho1estero1 formation was the rate-determining
step in bile acid biosynthesis. This is supported by the
finding of Shefer et al (1970) that when taurodeoxycholate
was infused intraduodenally into rats with a biliary
fistula, the conversion of radioactive cholesterol into
bile acids was markedly inhibited, whereas there was no
effect on the rate of conversion of radioactive 7ot -hydroxy-
cholesterol into bile acids. Hence the mechanisms which
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regulate the activity of the enzyme, cholesterol 7o( -
hydroxylase, in vivo will also control the rate at which
cholesterol is converted into bile acids. The object of
this research has been to study the manner in which this
enzyme is controlled in vivo, with a view to understanding
the mechanisms which regulate cholesterol catabolism in
rat liver.
As discussed in sections 1 and 3, the radioactive
tracer assay used by workers in this and other laboratories
to measure the activity of cholesterol 7cf, -hydroxylase is
fraught with assumptions regarding substrate pool sizes and
equilibration of tracer cholesterol. An unambiguous method
was established which measured directly the total mass of
product, 7 -hydroxycholesterol, formed in the reaction from
endogenous cholesterol using a gas liquid chromatographic
technique. Pig. 12 shows that the observed rate of formation
of 7o( -hydroxycholesterol in liver microsomal incubations
was approximately the same whether measured by the radio¬
active assay or by the GLC assay. This suggests that the
tracer cholesterol added in acetone solutinn equilibrates
rapidly with the endogenous cholesterol of liver microsomes,
the rate of equilibration being greater than the rate of
the hydroxylation reaction. The effect of adding significant
amounts of exogenous cholesterol was not investigated, nor
was theeffect of adding the cholesterol in a different
medium. Mosbach and his coworkers (Shefer et al 1968)
added significant amounts of endogenous cholesterol to their
incubations and Mitropoulos and Balasubramaniam (1972) added
radioactive cholesterol suspended in Tween 80. These latter
workers showed that in their experiments (4- C) cholestero
added in Tween 80 did not equilibrate uniformly with all
the endogenous cholesterol. This discrepancy might be due
to the mode of addition of radioactive substrate, or to a
difference in the method used to prepare liver microsomes.
In our experiments, however, it appears that measurement
of the initial rate of conversion of radioactive tracer
cholesterol into radioactive 7o<, -hydroxycholestero 1,
coupled with measurement of the total substrate pool, is a
valid means of estimating the specific activity of the
enzyme.
The specific activity of cholesterol 7c* -hydroxylase
in liver microsomes from rats maintained on the commercial
pellet diet was of the order of 30 pmoles per minute per
mg of microsomal protein. If it is assumed that the con¬
version of cholesterol to 7e*. -hydroxycholesterol is the
only rate-limiting step in the transformation of cholestero
to bile acids, then this rate should give a measure of the
rate of formation of bile acids in vivo. For a 10 g liver
and a microsomal protein content of 12 mg per g of liver
microsomes, this in vitro enzyme activity corresponds to a
rate of formation of approximately 2 mg of bile acids per
24 hours. The rate of formation of total bile acids in
rats fed on a commercial diet has been estimated to be
approximately 5 mg per 24 hours (Strand 1963). Thus
cholesterol 7o(. -hydroxylase activity measured in vitro is
of the same order as the rate of formation of bile acids
in vivo, providing further evidence that this enzyme may be
rate-limiting in bile acid synthesis. The discrepancy
between these values could be due to loss in enzyme
activity during the preparation, or to a low yield of
microsomes per unit liver weight. There is evidence to
suggest that other steps in bile acid biosynthesis might
become rate-limiting under certain conditions. For
example, it has been shown that the enzyme catalysing the
1 2ck -hydro xylation of 7 o(> -hydroxycholest-4-ene-3-one (step
D, Fig. 2), which may have a role in regulating the
relative proportions of cholic and chenodeoxycholic acids,
is activated following starvation (Johansson 1970).
Further evidence that cholesterol 7o(, -hydroxylase is
rate-1imiting in bile acid formation comes from the
effect of different in vivo treatments on the enzyme
activity measured in vitro. Cholestyramine feeding
increased cholesterol 7-hydroxylase activity, in agree¬
ment with previous reports. The enhancement in this case
was three to four-fold. Other workers have reported
increases in enzyme activity ranging from two-fold
(Mitropoulos and Balasubramaniam 1972) to six-fold (Boyd
et a 1 1 969). The magnitude of the increase probably
depends on the control diet on which the animals are main¬
tained. Table 3 demonstrates that cholesterol 7o(. -
hydroxylase activity is influenced by diet. This effect
might be caused by a direct action of dietary constituents
on bile acid absorption from the gut, as discussed in
.Section 4 (Part B) , but it might also result from an effect
of the diet on intestinal micro-organisms. Intestinal
bacteria can modify the chemical structure of bile acids.
Since certain of these secondary bile acids are only poorly
absorbed from the gut, these will not exert a feedback
effect on the enzyme system. Gustafsson et al (1957)
showed that the half-life of cholic acid was greater in
germ-free rats than in conventional rats.
When the effect of various physiological stimuli on
the activity of an enzyme measured in vitro are investi¬
gated, the enzyme must be assayed under conditions of
saturating substrate concentration. In the case of the
membrane-bound enzyme, cholesterol 7o< -hydroxylase, the
hydrophobic substrate cholesterol is not presented to the
enzyme in true solution and hence the term 'concentration'
is not valid. Also, since liver microsomal preparations
probably contain many binding sites for cholesterol other
than the 'active' site for cholesterol hydroxylation, the
kinetics which are normally applied to enzyme systems in
solution cannot be applied to liver microsomal cholesterol
7 &-hydroxylase. Microsomal cholesterol probably exists
in distinct heterogeneous pools, some of which might be
involved in membrane structure and restrained from reacting
with the enzyme. If the pool of 'metabolically active'
cholesterol does not saturate the enzyme system, then the
rate of formation of 7C. -hydroxycholesterol might depend on
the rate of supply of substrate to this pool. In 1961 Myant
and Eder reported that the increase in bile acid biosyn¬
thesis in the bile fistula rat was preceded by an increase
in the rate of hepatic cholesterol biosynthesis. They sug¬
gested that bile acid biosynthesis might be enhanced as a
passive consequence of the increased supply of substrate
cholesterol. Cholesterol supplied in the diet can also
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serve as a precursor of bile acids (Siperstein and
Chaikoff 1952). The increase in 7t* -hydroxycholesterol
formation by liver microsomes from rats fed a high choles¬
terol diet might also be a consequence of enlargement of a
'substrate pool'. However, the demonstration that the
rate of formation of 7cA -hydroxycholesterol is first order
with respect to microsomal protein concentration suggests
that the enzyme is in fact operating under conditions
where the substrate is saturating. There is additional
evidence to suggest that the rate of supply of substrate
cholesterol can be enhanced without affecting the rate of
7ot-hydroxycholesterol formation. Tomatine feeding was
shown to result in an increased rate of hepatic cholesterol
biosynthesis without affecting cholesterol 7c*. -hydroxylase
activity. Tomatine complexes with cholesterol in the gut
and prevents it from being absorbed, however it does not
interfere with bile acid absorption (Cayen 1971). Choles¬
tyramine feeding, which inhibits the intestinal absorption
of both cholesterol and bile acids, was shown to stimulate
both hepatic cholesterol biosynthesis and cholesterol 7o* -
hydroxylase. These results suggest that hepatic cholesterol
biosynthesis is under the feedback control of absorbed
cholesterol, whereas cholesterol catabolism is controlled
by bile acid absorption.
The relative proportions of 'metabolically active' and
'metabolically restrained' cholesterol in liver microsomes
are unknown. A possible model for cholesterol compartmentation
in liver microsomes is proposed in Fig. 36. Pool 1 represents
•metabolically inactive•cholesterol which is probably












involved in membrane structure and equilibrates at a slov
rate with the 'metabolically active' pool 2. Pool 2 can be
converted to bile acids or excreted as faecal neutral
sterols, and is replenished by de novo hepatic synthesis
and by cholesterol absorbed from the intestine. Exogenous
1 4
(4— C) Cholesterol added in acetone solution equilibrates
equally well with both pools 1 and 2 as demonstrated by the
results presented in Section 3 (Part F). Preincubation
1 4
of (4- C) cholesterol with liver microsomes prior to
starting the reaction with NADPH was found to result in a
1 4
small but significant increase in (4- C) 7-hydroxycholes-
terol formation. This can be explained by postulating the
existence of a third pool of cholesterol, present as the
enzyme-substrate complex. Preincubation would then allow
/ 14 x
(4- C) cholesterol to equilibrate with this pool, this
equilibration proceeding at a slov rate (K3, Fig. 36).
The results shown in Table 13 suggest that this pool repre¬
sents at most 0.5of the total endogenous microsomal
cholesterol. In these experiments the time for preincuba¬
tion was 10 minutes, but the half-time for the maximal
effect to be obtained was estimated to be approximately 5
minutes. Using this value, the rate of formation of
enzyme-cholesterol complex, E, can be calculated for a
typical experiment:
E = (0.25/100 X 200) pg cholesterol transferred per
5 minutes per 10 mg protein.
= 25 praoles per minute per mg microsomal protein.
This value is of the same order as the rate of cholesterol
7c<-hydroxylation obtained in these experiments. Thus the
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rate of formation of enzyme-cholesterol complex might be
rate-limiting in cholesterol 7o^ -hydroxylation.
This could explain the lack of correlation between
cholesterol 7c* -hydroxylase activity and the cytochrome P450
content of rat liver microsomes. Cytochrome P450 is impli¬
cated in cholesterol 7c* -hydroxylase as demonstrated by the
inhibition of the enzyme by carbon monoxide which is
reversed by monochromatic light at 450 nm. The administra¬
tion of barbiturates, such as phenobarbitone, which induce
drug hydroxylase activity also induce liver microsomal
cytochrome P450 content and the activity of the flavoprotein
NADPH cytochrome c reductase, suggesting that these electron
transferring components are rate-limiting (Orrenius et al
1965). However there is no correlation between cytochrome
P450 content and cholesterol 7o( -hydroxylase activity.
Although phenobarbitone increased the total activity of
enzyme in the liver there was no change when activity was
expressed on the basis of microsomal protein concentration.
Other instances have been recorded where cytochrome
P450-dependent hydroxylation was not proportional to
cytochrome P450 content. For example, the activity of
ethylmorphine demethylase was found to be three-fold greater
in male rats than in female rats, whereas there was only a
20^ difference in cytochrome P450 content (Gillette and
Gram 1969). These workers correlated the difference in
enzymic activity with the increase in activity of NADPH
cytochrome P450 reductase activity which occurs in the
presence of substrate, suggesting that the rate-limiting
step in ethylmorphine metabolism is the rate of reduction
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of the cytochrome P450-substrate complex. Schexikman et al
(1967b) shoved that the difference in aminopyrine demethylase
activity betveen male and female rats could be correlated
vith the magnitude of the Type I spectral change which is
produced when the substrate is added to aerobic suspensions
of liver microsomes. These workers suggested that the rate-
limiting factor was a substrate binding component unique
to the cytochrome P450. No sex difference has been
observed in cholesterol 7e* -hydroxylase activity although
a systematic study has not been made. The results presented
in Section 5 clearly demonstrate that cholesterol 7o<. -
hydroxylase and aminopyrine demethylase are controlled by
different mechanisms in vivo.
Some workers have proposed the existence of a 'cholesterol-
specific' cytochrome P450 to explain the lack of correlation
between cholesterol 7 o*. -hydroxylase and liver microsomal
cytochrome P450 content (Wada et al 1969; Atkin et al 1972).
They propose that this cytochrome, rate-limiting in cholesterol
7ot-hydroxylation, is present in such a small proportion to
the total cytochrome P450 that its induction following
biliary diversion is not observed. The difference in sensi¬
tivity of different hydroxylases to carbon monoxide was
originally interpreted by some workers as being indicative
of a plurality of cytochromes which interact vith carbon
monoxide to different extents. However, Bjorkhem (1972)
has recently correlated the sensitivity of different hydroxy¬
lases to carbon monoxide with the presence or absence of an
isotope effect in the insertion of thehydroxyl group. For
example, the 7oL -hydroxylation of taurodeoxycholic acid,
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which is insensitive to carbon monoxide, may still involve
cytochrome P450, as the rate-limiting step in the reaction
is the removal of the hydrogen atom at C^. No significant
isotope effect was observed in the 7<* -hydroxylation of
cholesterol by rat liver microsomes (Bjorkhem 1971),
suggesting that the breaking of the carbon-hydrogen bond
is not rate-limiting in this reaction, perhaps a consequence
of the allylic position of Cj in the cholesterol molecule.
Only two forms of cytochrome P450 have as yet been dis¬
tinguished in liver microsomes on the basis of the spin
state of the haem moiety (Jefcoate et al 1969), but there
is no evidence as to whether these can be subdivided into
distinct species of cytochrome. Levin and Kuntzmann (1969)
showed that the cytochrome P450 of liver microsomes labelled
in the haem moiety decayed biphasically in vivo, the half-
lives of the two components being 48 hours and 7 hours for
the high spin and low spin forms respectively. However the
half-life of cholesterol 7o<. -hydroxylase in vivo was
estimated to be approximately 3 hours. Thus although the
results can be explained by postulating the existence of a
distinct cytochrome P450, they can also be accounted for by
proposing the existence of another rate-limiting step,
specific for cholesterol. As suggested above, this step
could be the formation of an enzyme-cholesterol complex.
This might be regulated in turn by a eyeloheximide-sensitive
factor having a half-life in vivo of 3 hours which is
induced following biliary diversion. This rate-limiting
component could be a binding protein which holds the
cholesterol molecule in the correct conformation at the
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active site of the enzyme complex, or it might be a 'carrier
protein' for transporting substrate cholesterol through the
endoplasmic reticular membranes. Ritter and Dempsey (1971)
reported that a heat-stable protein factor isolated from
105,000 g rat liver supernatant stimulated several steps
in cholesterol biosynthesis. However this protein, which
can bind cholesterol, is probably not involved in choles¬
terol 7c* -hydroxylase, as heat-stable supernatant from the
livers of cholestyramine-treated rats had no effect on
cholesterol 7c* -hydroxylase activity in liver microsomes
from control rats (Scholan 1969).
Provided that the rate-limiting component of choles¬
terol 7c< -hydroxylase is saturated, then the enzyme will
operate under Vmax conditions, regardless of whether the
hydroxylation site on the P450 is saturated with cholesterol.
It is interesting to note that the specific activity of
aminopyrine demethylase is two orders of magnitude greater
than the specific activity of cholesterol 7c* -hydroxylase.
It is possible that the hydroxylation of cholesterol by
cytochrome P450 proceeds at an equally fast rate, but that
the overall rate is determined by the rate at which choles¬
terol is transferred from pool 2 to pool 3 (Fig. 36). This
hypothesis necessitates an explanation as to why cholesterol
does not interact directly with the cytochrome P450 but
requires in addition another component. This could be a
consequence of the hydrophobicity of the cholesterol
molecule. Table 14 demonstrates that pregn-5-ene-3£ -ol
did not produce a difference spectrum with rat liver micro¬
somes whereas dehydroepiandrosterone, pregnenolone and
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androst-5-ene-3Q -ol all produced Type I difference spectra.
Since pregn-5-ene-3 -o 1 differs from pregnenolone in the
lack of a keto group at C^q» and from androst-5-ene-3^ -ol
in the 2-carbon side-chain at Cit appears that there is
a limit to the hydrophobicity of substrates which can inter¬
act with cytochrome P450. Thus cholesterol, having an 8-
carbon side chain at may be structurally unsuited to
interact directly with cytochrome P450 and therefore
requires an additional component. The specificity of
this component for cholesterol is demonstrated by the
results obtained on the NADPH-dependent oxidation of
steroid substrates having a structure similar to choles¬
terol. The oxidation of these substrates was not affected
by cholestyramine feeding, a treatment which induces
cholesterol 7c* -hydroxylase activity. It is possible that
dehydroepiandrosterone, pregnenolone and androst-5-ene-3p -ol
can interact directly with cytochrome P450. The rates of
oxidation of these substrates, like that of aminopyrine
demethylase, were two orders of magnitude greater than
cholesterol 7cx -hydroxylase activity. These compounds
probably inhibit the hydroxylation of cholesterol by
competing for reducing equivalents from the mixed function
oxidase system, however the activating effect of amino¬
pyrine remains unexplained. The results suggest that
pregn-5-ene-3 $-ol is not oxidised by a mechanism involving
either cytochrome P450 or cholesterol 7oi -hydroxylase, but
that a peroxidative mechanism is involved, analogous to the
'autoxidation' of cholesterol by liver microsomes. Both of
these systems are markedly inhibited by <£ -mercaptoethylamine.
The hypothesis of a rate-limiting factor for choles¬
terol 7<* -hydroxylase, distinct from the electron transfer¬
ring components of the mixed function oxidase system, could
be tested by the fractionation of these components from
liver microsomes followed by reconstitution of enzyme
activity, however attempts at solubilisation and fractiona¬
tion of the cholesterol 7c* -hydroxylase enzyme system have
so far met with little success.
The proposed control mechanism for cholesterol 7o(. -
hydroxylase is similar to that postulated for the mechanism
of action of adrenocorticotrophic hormone (ACTH) on the
cholesterol side chain cleavage enzyme of adrenal cortex
mitochondria (Simpson et al 1972). This system also
involves interaction of substrate cholesterol with a
membrane-bound mixed function oxidase system of which
cytochrome P450 is the terminal oxidase (Simpson and Boyd
1967). Ether anaesthesia stress increases the rate of
formation of pregnenolone from cholesterol by adrenal
cortex mitochondria in vitro, and evidence has accumulated
which suggests that the rate-determining step in this system
is the rate of formation of an enzyme-cholesterol complex.
In this system cholesterol forms a high spin complex with
cytochrome P450, and hence the amount of cholesterol
present as enzyme-substrate complex can be quantitated,
either by using electron spin resonance techniques, or by
measuring the extent of pregnenolone binding (Simpson _e_t
al 1972; Jefcoate et al 1972). Pregnenolone forms a
Type II complex with adrenal cortex mitochondrial
cytochrome P450, interpreted as being a result of
displacement of enzyme-bound cholesterol, with resultant
conversion of the cytochrome from the high spin to the low
spin state. The product of liver microsomal cholesterol
7ok -hydroxylase, 7c* -hydroxycholesterol, although it inhibit
the enzyme,does not produce a difference spectrum with liver
microsomes. This suggests that either product inhibition
does not occur as a result of a displacement of substrate
from cytochrome P450, or that cholesterol does not form a
high spin complex with liver microsomal cytochrome P450 as
it does with adrenal mitochondrial cytochrome P450. This
latter explanation is supported by the finding that induc¬
tion of cholesterol 7c* -hydroxylase activity is not
paralleled by a change in the proportion of high spin
cytochrome P450 as measured by amine binding techniques
(Grimwade 1971).
Cholesterol metabolism in adrenal cortex also resembles
that in liver microsomes in being regulated by a
cycloheximide-sensitive factor (Garren et al 1965). However
in the former case the half-life of this factor is of the
order of several minutes, as opposed to 3 hours for
cholesterol 7c* -hydroxylase, in keeping with the different
physiological functions of these two systems. A further
similarity between cholesterol metabolism in these two
organs is the increased rate of substrate supply which
accompanies enhancement of substrate degradation in res¬
ponse to physiological stimuli. Thus biliary diversion
results in an increase in the rate of hepatic cholesterol
synthesis and stress results in an increase in the rate of.
cholesterol ester hydrolysis in rat adrenal cortex cells
(V. H. Trzeciak, personal communication). Thus in these
two organs, each having very different metabolic functions,
the control mechanisms which have evolved for cholesterol
metabolism are remarkably similar. The enzymic control of




THE DECOMPOSITION PBODUCT OP CI10LE6T-5-CNE-3 . 7o(. -DIOL
■DIACBTATE ON CrAS LlyUID CHROMATOGRAPHY
Cholest-5-ene-3 ^ , 7o*. -diol diacetate, when subjected
to gas liquid chromatography under the conditions described
in Section 2, resulted in a chromatogram having a single
symmetrical peak with retention time relative to cholesterol
of 0.64. However, Van Lier and Smith (1967) reported a
retention time relative to cholesterol of 1.69 for this
compound using the same liquid phase SE 30. The discrepancy
between these values suggested that perhaps decomposition
was taking place in our experiments. This was confirmed
by the following procedure.
Combined gas chroraatography-mass spectrometry using
the same gas chromatographic conditions as above showed the
eluted compound to have a molecular ion of m/e 366.
Cholest-5-ene-3 , 7(*-diol diacetate has a molecular weight
of 486. However, this in itself was not indicative of gas
chromatographic decomposition as direct injection of
cholest-5-ene-3 <£> , 7o^ -diol diacetate into the mass spectro¬
meter also yielded a spectrum with a molecular ion of m/e
366. However, when the eluted component was passed over
•neutral' palladium using hydrogen as the gas chromatographic
carrier gas prior to entry into the mass spectrometer, the
spectrum obtained showed a molecular ion of m/e 372. This
spectrum was identical with that of 5^> -cholestane. This
evidence indicates that cholest-5-ene-3 (3 , 7-diol
diacetate has been decomposed following injection into the
gas chromatograph to give a cholestatriene.
91
buggested structures for the decomposition product are
3 5 7
Zb. ' ' -cholestatrien© (I) vhieh could be formed by the
thermal elimination of two molecules of acetic acid, or the
2 4 • 6 f j
rearrangement product/^' -cholestatriene (TLj/lhe identity
of this cholestatriene was not established.
SE 3Q s,
235 °C
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